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 ABSTRACT 
 
The xylem-limited bacterium, Xylella fastidiosa, is the causal agent of several 
plant diseases, most notably Pierce’s Disease of grapes and citrus variegated chlorosis. 
We report on the isolation and characterization of the first virulent phages for X. 
fastidiosa, Xfas103, Xfas106, Xfas303, Xfas304, with host ranges extending to 
Xanthomonas.  Efficiency of plating on X. fastidiosa strain Temecula or Xanthomonas 
strain EC-12 ranged from 1.41 ൈ 10-1 to 2.29 ൈ 10-3, depending on propagating and 
plating host. Phages propagated on homologous hosts had an observed adsorption rate 
constant of (4.33 ± 0.28) ൈ 10-12 ml cell-1 min-1 for strain Temecula, and ranged from 
(4.58 ± 0.30) ൈ 10-10 to (7.26 ± 0.42) ൈ 10-10 ml cell-1 min-1 for strain EC-12. 
Siphophages Xfas103 and Xfas106 exhibit over 80% nucleotide identity to each other 
and are syntenic to phage BcepNazgul. Here it is proposed that phage BcepNazgul is the 
founding member of a novel phage type, to which Xfas103 and Xfas106 belong. 
Podophages Xfas303 and Xfas304 show no significant DNA homology, both encode for 
a single subunit RNA polymerase at the right end of the class II gene cluster, and are 
new members of the phiKMV-like phage type. The four phages utilize Type IV pili as 
receptors to infect strains Temecula and EC-12. The phages may be useful as agents for 
an effective and environmentally friendly strategy for the control of diseases caused by 
X. fastidiosa. 
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 CHAPTER I  
INTRODUCTION AND LITERATURE REVIEW 
 
The pathogen: Xylella fastidiosa 
Classification 
Xylella fastidiosa is a Gram-negative member of the Gamma-proteobacteria. It is 
a rod-shaped, non-flagellated bacterium, with distinctive rippled cell walls resembling 
Rickettsia (1-2). Two types of pili are located at the poles: type I pili (T1P), 0.4 to 1.0 
µm in length, and type IV pili (T4P), 1 to 6 µm in length (1, 3). T1P are important for 
attachment, aggregation, and biofilm formation, whereas T4P are used for twitching 
motility and migration (4). X. fastidiosa is a fastidious aerobe that colonizes the 
nutritionally poor environmental niche of plant xylem vessels where it may or may not 
be the causal agent of disease, depending on the plant host (5).  
Relatedness to Xanthomonas 
The family Xanthomonadaceae is a wide-spread family of bacteria belonging to 
the Gram-negative Gamma-proteobacteria, including the two plant-associated genera 
Xanthomonas and Xylella, and the related genus Stenotrophomonas (6). The genus 
Xanthomonas currently comprises 27 species with validly published names that are 
important crop and horticultural pathogens (7). Genome analysis of different X. 
fastidiosa strains suggests that X. fastidiosa is most closely related to plant pathogenic 
members of the genus Xanthomonas, but with a genome reduced in size and with 
considerably lower GC content. This presumed evolutionary reduction may be related to 
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 the fact that X. fastidiosa is xylem limited, in contrast to Xanthomonas (8). Individual 
species can comprise multiple pathovars. Pathogenic species and pathovars show a high 
degree of host plant specificity with many exhibiting tissue specificity, invading either 
the xylem elements of the vascular system or the intercellular spaces of the mesophyll 
parenchyma tissue of the host (9). Xanthomonas vascular pathogens such as X. oryzae 
pv. oryzae and X. campestris pv. campestris persist as epiphytes on plant surfaces before 
they enter the plant via natural openings such as hydathodes, stomata or wounds, and 
migrate to the lateral veins where they multiply. Inside the plant tissue, Xanthomonas 
can subsequently invade the surrounding mesophyll tissues resulting in disease 
symptoms (9). X. fastidiosa does not need plant invasion mechanisms, because cells are 
introduced into the xylem by insect vectors. In fact, genome analysis of X. fastidiosa has 
shown the presence of several genes previously only identified in animal pathogens, and 
it has been suggested that they may facilitate attachment and growth in insect vectors 
(10-11). Many genes have been implicated in the virulence in Xanthomonas species and 
many of these homologs are present in X. fastidiosa. These include T1P and afimbril 
adhesions for attachment and biofilm formation (12-13), xanthan-like 
exopolysaccharides (EPS) similar to Xanthomonas xanthan gum (12-14), a type II 
secretion system used to export exoenzymes to degrade the plant cell wall (12), and T4P 
used for twitching motility (12-13). Additionally, because of its nutrient-poor 
environment, X. fastidiosa has special mechanisms to concentrate and absorb nutrients. 
It is believed that it possesses EPS glycocayx-like fibers that may function in ion-
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 exchange, nutrient binding within cell aggregations, and conserving and concentrating 
digestive enzymes released by the bacterium (15). 
Vectors 
Several species of sharpshooter leafhoppers (Homoptera; Cicadellidae) and 
spittlebugs (Homoptera: Cercopidae) have been reported to be vectors of X. fastidiosa 
(16). For successful transmission of X. fastidiosa to plants, the insect must first acquire 
the bacterium from an infected plant. Second, the bacterium must attach to the insect’s 
forgut cuticle. Lastly, the vector must feed upon and transmit the bacterium to a 
susceptible host. The ability of a vector to successfully acquire and transmit the 
bacterium depends on the combination of vector species and host plant (17). However, it 
appears that all species of sharpshooters can transmit all strains of X. fastidiosa, although 
with different degrees of efficiency (16). Sharpshooters are polyphagous insects (i.e., 
they feed on a wide variety of plants). Weeds found in riparian areas harbor X. fastidiosa 
and often serve as the primary source of inoculum for sharpshooters who then transmit 
the pathogen to crops. Infectivity is not lost in adults, so insect vectors are able to 
transmit the pathogen to several susceptible hosts for months after initial acquisition 
(16).  X. fastidiosa utilizes T1P to successfully attach to the forgut of potential vectors 
(10). The attachment must be strong because of the considerable force asserted by the 
insect when feeding. Once attached, the bacterium is able to replicate within the insect’s 
forgut. For an insect vector to acquire X. fastidiosa from an infected plant,  a minimum 
concentration of 104 cells/g of plant tissue are required for most plants, and 106-
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 107cells/g of plant tissue are required for successful acquisition from grapes (18). 
However, as few as 100 cells are required for transmission from vector to plant (19).  
Diseases caused by subspecies 
Xylella fastidiosa causes a variety of diseases in over 150 plant species (5, 15, 
20-29). Economically important diseases include Pierce’s Disease (PD) of grape, citrus 
variegated chlorosis (CVC), phony peach disease (PPD), periwinkle wilt, almond leaf 
scorch (ALS), oleander leaf scorch (OLS) and coffee leaf scorch (CLS) (10). All strains 
of Xylella are currently classified as X. fastidiosa, with five recognized subspecies: (i) X. 
fastidiosa subsp. fastidiosa (most notable for PD); (ii) X. fastidiosa subsp. multiplex 
(most notable for PPD); (iii) X. fastidiosa subsp. pauca (most notable for CVC); (iv) X. 
fastidiosa subsp. sandyi (most notable for OLS); (v) X. fastidiosa subsp. tashke 
(associated with disease on the ornamental tree Chitalpa tashkentensis) (30-31). 
Except for reports of pear leaf scorch in Taiwan (32) and PD in Kosovo (33), diseases 
caused by X. fastidiosa are restricted to tropical and subtropical areas of the Americas, 
although some tree leaf scorch diseases occur in much colder climates (16). Crop 
diseases caused by X. fastidiosa appear to be “new encounter” diseases caused by 
endemic X. fastidiosa. Disease symptoms are often only observed in species exotic to the 
Americas, whereas X. fastidiosa is found in hundreds of symptomless indigenous plants 
(16).  
Symptoms of disease are only observed when xylem vessels are highly colonized 
by the bacterium. The xylem transports water and soluble mineral nutrients from the 
roots throughout the plant, and used to replace water lost during transpiration and 
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 photosynthesis. Xylem vessels are interconnected by bordered pits, which allow the 
passage of xylem sap, but block the passage of larger objects (such as bacteria) by a 
membrane (34). X. fastidiosa does not have a Type III secretion system, but Type II-
secreted effectors including several β-1,4 endoglucanases, xylanases, xylosidases, and 
one polygalacturonase that are likely involved in degradation of different components of 
pit membranes and allow X. fastidiosa to spread between neighboring vessels (12-13, 
35). Xylem vessels become occluded by dense colonization. When colonization becomes 
excessive, biofilms form along the xylem vessel and can block water flow. Limited 
water flow leads to water stress during high temperatures and can result in scorching 
symptoms.   
Symptoms of PD in grapes begin with drying and necrosis of leaf margins, 
resulting in a “scorched” appearance. Scorched leaves usually drop from the distal end 
of the petiole, leaving bare petioles attached to canes, resulting in a “matchstick” 
appearance. Further defoliation, shoot dwarfing and cane stunting may occur. Vines may 
be reduced in growth, fruits may take on a dehydrated appearance, and eventual vine 
death may occur (36). PD precludes commercial production of European grape (V. 
vinifera) in much of the southeastern United States, since the pathogen and vector are 
endemic to the region. The first reports of PD in California date back to the 1880’s, 
where the disease was usually confined to “hot spots” near water sources and riparian 
areas (5). The disease did not gain prominence until the introduction of the exotic glassy-
winged sharpshooter (Homalodisca vitripennis, formerly known as H. coagulata), which 
is able to spread PD much more efficiently than the native blue-green sharpshooter (16).  
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 Symptoms of CVC are observed on younger trees. Trees are generally not killed, 
but fruit production is severely reduced. Leaves develop small interveinal chlorotic 
spots, and wilting may occur. Fruits remain small, have high sugar content with hard 
rinds, and ripen early. Chronic symptoms include stunting and dieback of twigs (37). 
CVC was first reported in only a few orange trees in Argentina in 1987 (38). In less than 
a decade the disease had spread throughout South America (16). The rapid spread of this 
previously unknown disease suggests that the causal agent was an introduced strain of X. 
fastidiosa (16). Another theory, based on the close genetic homology of coffee strains of 
X. fastidiosa to citrus strains (39), is that the citrus strains may have recently evolved 
from endemic coffee strains. The rapid spread of CVC from Argentina to Brazil, and its 
ability to cause disease in grapes demonstrates the serious threat that CVC strains could 
pose to citrus production in North America and the potential for yet unknown diseases in 
additional crop and native plant species (16). 
Symptoms of CLS on coffee plants first appear on young shoots as large 
necrotic-scorched areas on the tops or margins of mature leaves. New growth is stunted 
and pale. Fruit size and yield is also impaired.  Premature fall of leaves and fruit is a 
more prominent symptom of disease the scorching. Water stress leads to more severe 
symptoms (37).  
Peach trees infected with PPD generally decline in vigor and are more 
susceptible to other diseases and pests. Early symptoms include stunted young shoots 
that have earlier, more numerous and darker leaves than normal. Trees show early 
blooming and both leaves and flowers remain on the shoots longer than normal. Twigs 
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 display increased lateral branching with shortened internodes. Lateral branches grow 
horizontally. Fruits are small and ripen early. Trees with PPD, when completely 
infected, appear uniform across the top, resembling a trimmed hedge (37).  
Bacterial leaf scorch (BLS) affects many different shade tree species, including 
the American elm, red maple, sweet gum, sycamore and a several species of oak. 
Symptoms vary by tree species, but most include chloritic marginal leaf scorching. 
Symptoms appear in late summer to early fall. Leaves may curl and drop prematurely, 
branches die, and in some tree species the entire tree can die (37). 
Current control measures 
There are no methods proven to cure PD (16). Nearly all popular grape cultivars 
of European (V. vinifiera), American (V. labrusca) and French-American hybrid grapes 
are killed by PD (5). Species native to the southeastern United States (V. muscadine) 
show varying levels of resistance to PD, but are not desirable for wine production. The 
removal of infected grapevines only reduces secondary (vine to vine) spread of X. 
fastidiosa (40), and is generally ineffective in reducing the spread of disease within a 
plot because X. fastidiosa is primarily spread from sources outside vineyards, such as 
riparian areas, rather than vine to vine (16).  
Infective overwintering adult vectors are responsible for establishing most 
chronic infections in early spring (16).  Egg parasitoids such as Gonatocerus sp. have 
been used with limited success to control vector populations. However, their populations 
decrease strongly during winter when vector egg production is low, and therefore the 
first generation of vectors are only slightly parasitized (16). Significant efforts have been 
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 made to control vector populations using systemic insecticides, especially neonicotinoids 
(imidaclorid). Area-wide insecticide control programs have been established, but have 
only been partially successful (40), and may be potentially harmful to the environment 
(41-42).  
Given the current limited success in controlling X. fastidiosa, and the risk of its 
spread, there is a need for the development of an effective and environmentally friendly 
X. fastidiosa control strategy. Recently, there has been renewed interest in the 
application of bacteriophages (phage) for the control of bacterial plant disease (43). 
Phages have many attractions for both prophylactic and therapeutic control of bacterial 
plant diseases.  Phages are self-replicating and self-limiting, specific to target bacteria 
and can be targeted against bacterial receptors that are essential for pathogenesis, 
without posing any harmful effects to plants, animals, humans or associated beneficial 
microflora (43). 
Bacteriophages 
History 
Bacteriophages (or phages) were discovered independently by Frederick W. 
Twort in 1915 and by Felix d’Herelle in 1917. Phages are viruses of bacteria, and with 
an estimated viral population of greater than 1031, are the most widely distributed 
biological entity in the biosphere (44). Phage can confer key phenotypes on their host 
and they play a key role in regulating bacterial populations the environment (45). The 
phage-bacterium relationship varies from the simple predator-prey model to a complex 
relationship that promotes the survival and evolutionary success of both (46). 
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 Phages have played and continue to play a key role in bacterial genetics and 
molecular biology. In the 1930s and the years that followed, virologists such as Salvador 
Luria and Max Delbrück utilized phages as model systems to investigate many aspects 
of virology, including virus structure, genetics, and replication. These relatively simple 
agents have played a central role in some of the most significant discoveries in 
biological sciences, from the identification of DNA as the genetic material (47), to the 
deciphering of the genetic code (48), to the development of molecular biology (49). 
Research on phages has aided our understanding of the basic molecular mechanisms of 
gene action and biological structure. Phage genomics is revealing novel biochemical 
mechanisms for replication, maintenance and expression of the genetic material (49).  
Classification 
The dsDNA tailed phages, or Caudovirales, account for 96% of all the phages 
reported in the scientific literature (50). Tailed phages are further organized into families 
based on tail morphology; Myoviridae (long, contractile tails), Siphoviridae (long-
flexuous, non-contractile tails) or Podoviridae (short-stubby, non-contractile tails). 
Due to extensive mosaicism caused by frequent horizontal gene transfer events, 
the evolutionary relationships between phages cannot be easily established, and the 
concept of biological species or hierarchical lineages in the classical Linnaean sense are 
difficult to apply (51-52). DNA or amino acid identity relationships have been used to 
organize phages into groups (53-55), however the enormous diversity of phages has 
resulted in numerous phage groups with no obvious evolutionary linkage (56). A better 
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 model proposed organizes phages into “phage types” based on shared genome 
organization and life style (57). 
Phages can display one of two types of life cycle: virulent (lytic) or temperate 
(lysogenic). The phage life cycle consists of an extracellular search, attachment to 
susceptible bacteria, phage-genome uptake into bacteria, production of phage progeny, 
and subsequent release of these progeny into the extracellular environment (58). The 
extracellular search occurs via phage diffusion through an aqueous milieu. Phage contact 
with a host bacterium occurs via tail and tip proteins that have high affinity to specific 
bacterial surface molecules, including outer membrane proteins,  pili, flagella, 
oligosaccharides or lipopolysaccharides (LPS) (59). Type IV pili (T4P) have been 
previously identified as phage receptors for several P. aeruginosa phages (60-66). For 
many phages, this binding step is reversible, and may require a second irreversible 
binding step. After successful attachment (or adsorption) to a specific receptor on the 
bacterial cell surface, the phage genome and associated proteins are released into the cell 
(the capsid proteins are usually stripped off and remain outside the cell). Phages express 
early genes that allow the phage to redirect bacterial protein expression systems and 
regulate the production of new virions. Expression of late phage genes allow production 
of additional copies of the phage genome and structural proteins, which are subsequently 
assembled into new phage virion particles. The lytic pathway results in the eventual lysis 
of the host cell (time determined by the phage) and the release of progeny phage that are 
free to bind and infect new host cells (67). When a temperate phage infects a bacterium, 
it can either replicate by means of the lytic life cycle, or it can incorporate its DNA 
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 genome into the bacterium's genome and become a noninfectious prophage by means of 
the lysogenic life cycle. During the lysogenic cycle, phage expressed genes allow the 
phage genome to integrate into the host genome, and then suppress further expression of 
most phage genes, except those that are needed to maintain the lysogenic state. The 
prophage replicates with the bacterial host cell (or lysogen) until it is reactivated and 
resumes the lytic cycle (67). Phage induction is usually triggered by host stress caused 
by DNA damage. In the laboratory, prophages can be induced using mitomycin C or 
UV. Once induced, the phage goes through the typical lytic cycle, producing progeny 
phage and lyses the host cell. 
The canonical lysis cassette of phages that infect Gram negative bacteria encodes 
a holin, endolysin, and a spanin complex (68). The endolysin, a peptidoglycan-degrading 
enzyme, accumulates in the cytosol at the end of the replication cycle. The holin, a small 
hydrophobic membrane spanning protein, is essential for the endolysin to gain access to 
the outer membrane. Holin genes have enormous diversity, with more than 50 unrelated 
gene families having been described (68). Holins form a membrane lesion in the 
cytoplasmic membrane at a genetically predetermined time, which permeabilizes the 
inner membrane for the endolysin to degrade the peptidoglycan layer (68). In the 
absence of an intact peptidoglycan layer, the cell lyses due to internal osmotic pressure. 
The presence of a dual start motif in some holin sequences results in the production of a 
holin and anti-holin, and further optimizes lysis time and phage fitness (68-69). A holin 
and an endolysin constitute the essential minimum for programmed lysis in most cases, 
however several phages encode Rz/Rz1 proteins (68). The Rz, an inner membrane 
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 protein, and Rz1, an outer membrane lipoprotein, bind each other by C-terminal 
interactions, forming a complex that spans the entire periplasm. Once the endolysin 
destroys the cell wall, the spanin complexes oligomerize side-to-side and undergo a 
conformational change. The molecular basis of Rz and Rz1 function is currently 
unknown, but the complex is involved in the destruction of the outer membrane (70). 
Phage therapy 
Soon after their discovery, phages were utilized for the control of bacterial 
pathogens, also called phage therapy or phage biocontrol. Phage therapy was used in 
human and veterinary medicine to agricultural settings, and was initially used to 
successfully treat a variety of diseases ranging from typhoid and paratyphoid fevers, 
dysentery, cholera and pyogenic urinary tract infections (45, 71). With the introduction 
of broad-spectrum antibiotics in the 1940’s, the utilization of phage therapy mostly 
ceased (71). In Eastern Europe and the former Soviet Union, research and the application 
of phage therapy (often as a compliment to antibiotic treatment) have continued (71). 
There is a current renewed interest in phage therapy in the West due to the emergence of 
drug-resistant pathogenic bacteria as well as concerns over traditional pathogen control. 
Phages offer a safe and novel alternative to control plant pathogenic bacteria (72). The 
potential of phage therapy to control plant pathogens was investigated early after the 
discovery of phage (73). Recent examples of phage therapy for plant disease control 
listed in TABLE 1. Phage therapy for plant pathogens has been utilized for controlling 
plant pathogens either in the rhizosphere or phyllosphere. Both of these environments 
pose challenges for successful phage therapy. In the soil, only a low number of viable 
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phage  are available to attack target bacteria due to low rates of phage diffusion and high 
rates of phage inactivation (58). The phyllosphere is a harsh environment and phages 
applied to aerial tissues degrade rapidly due to UV and high temperature (74-77), can 
easily be washed away by rain, and are unable to infect in dry conditions (43, 58, 78). 
This transient survival of phages on plant leaf surfaces is a major limiting factor of 
phage treatment. The plant vascular system offers a unique opportunity to evaluate a 
closed “aqueous” system in which phage can be transported through the tissue and come 
in intimate contact with the causal pathogen. The vascular system is also a less harsh 
environment, in that phage are not exposed to UV.  
 
 
      
 
TABLE 1 Application of phage therapy for control of plant pathogens 
Host Disease Pathogen References 
Cabbage Black rot Xanthomonas campestris pv. campestris (79) 
Calla Lily Bacterial soft rot Erwinia carotovora subsp. carotovora (80) 
Citrus Citrus canker Xanthomonas citri subsp. citri (81) 
Citrus Citrus bacterial spot Xanthomonas fuscans subsp. citrumelonis (81) 
Geranium Bacterial blight Xanthomonas campestris pv. pelargonii (82) 
Mungbean Bacterial leaf spot Xanthomonas axonopodis pv. vignaeradiatae (83) 
Mushroom Bacterial blotch Pseudomonas tolaasii (84-85) 
Onion Leaf blight Xanthomonas axonopodis pv. allii (86-88) 
Pepper Bacterial spot Xanthomonas campestris pv. vesicatoria (79) 
Pomefruits Fireblight Erwinia amylovora (89-94) 
Potato Potato scab Streptomyces scabies (95) 
Rice Bacterial leaf blight Xanthomonas oryzae (96) 
Stonefruits Bacterial spot Xanthomonas arboricola pv. pruni (76, 97-99) 
Tobacco Bacterial wilt Ralstonia solanacearum (100-101) 
Tomato Bacterial spot Xanthomonas campestris pv. vesicatoria (75, 102-
104) 
Tomato Crown gall Agrobacterium tumefaciens (105) 
Walnut Walnut blight Xanthomonas campestris pv. juglandis (77) 
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 Phages are ubiquitous in the environment and can easily be isolated from water, 
soil, plant cuttings and sewage (106-107).  Samples can either be directly plated or 
enriched for phages in liquid culture with one or more bacterial hosts. Enrichment allows 
for the detection of phages that are initially found in low numbers. Liquid culture 
enrichment tends to select for rapidly growing virulent phages, which could bias 
selection for a single rapidly replicating phage, masking the appearance of slower-
growing but perhaps broader host range phages. Additionally, growth conditions may 
alter host gene expression of potential phage receptor sites. Once environmental samples 
are collected and processed, they must be evaluated for the presence of phage able to 
lyse the host of interest. A panel of pathogenic host strains may be tested in order to 
increase the diversity of isolated phages. Additionally, surrogate host bacteria may be 
used as phage isolation hosts as long as phages isolated against the surrogate host are 
also able to efficiently adsorb too, infect and replicate in the target pathogenic strains. 
The use of surrogate hosts has many advantages, including ease of handling, ease of 
culture, and lower pathogenicity. Examples of previous surrogate host use include the 
production of Mycobacterium tuberculosis phage D29 using the easier to grow and less 
pathogenic M. smegmatis (108), and the production of Listeria monocytogenes phage 
P100 using the non-pathogenic L. innocua (109). 
Generally, phages have narrow host ranges, often only infecting a particular 
strain or species of bacteria, whereas others may be able to infect numerous genera. Host 
range is determined by the ability of the phage to bind to the host surface, eject its DNA 
into the cell, and overcome potential bacterial CRISPR-Cas or restriction and 
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 modification systems (110). In a given field or plant, there are different populations of 
target bacterium that may or may not be sensitive to a given phage, and the open nature 
of agricultural systems allow movement of new pathogen strains into and out of crop 
populations.  
Phage therapy works by reducing the targeted pathogen (72, 111-113). Phage-
resistant mutant bacterial strains may arise during the course of phage therapy, and 
initial decline may be followed by recovery of phage-resistant bacteria. However, 
bacterial resistance to phage attack often comes at a metabolic cost to bacteria and can 
affect virulence related properties. If a phage can be targeted against a bacterial receptor 
that is essential for virulence, resistant mutants would have attenuated virulence (43). 
Additionally, bacterial-resistance is less likely to develop with the use of phage 
cocktails, where bacteria are challenged with multiple phages that recognize different 
receptor sites, the equivalent of a multidrug treatment (114).  
 Temperate phage should not be used for phage therapy for a number of reasons. 
First, the genomes of temperate phage may contain genes which alter the phenotype of 
the host cell when a lysogen is established, a process called lysogen conversion. 
Temperate phages may encode genes that are able to transform the host cell they infect 
into a more effective disease causing agent. Second, lysogens are immune to 
superinfection by the same phage or related phages due to repression of transcription 
caused by the resident prophage. A third concern is that many temperate phages are 
capable of generalized transduction, in which the phage is able to package and transmit 
host DNA to other cells. Like lysogenic conversion, generalized transduction has the 
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 potential to increase the disease causing potential of bacteria (114). For these reasons, 
temperate phages (or at least phages able to form stable lysogens) should not be used for 
phage therapy. Determining the temperate status of a novel phage is not always easy. 
Genomic characterization may identify genes commonly associated with lysogeny, such 
as repressor genes and integrases, although the diversity of phage genomes complicates 
their detection. The absence of plaque turbidity and the inability to form a stable lysogen 
under given culture conditions in a particular bacterial strain, does not necessarily mean 
that a phage is incapable of forming lysogens under different conditions or in other 
bacterial strains (114). 
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 CHAPTER II 
ISOLATION AND BIOLOGICAL CHARACTERIZATION OF PHAGES FOR 
Xylella fastidiosa  
 
Introduction 
The plant pathogenic bacterium, Xylella fastidiosa, is the cause of a number of 
economically important diseases, including Pierce’s Disease (PD).There is currently no 
cure for disease caused by X. fastidiosa. Limited control efforts are directed toward 
preventing the spread of the disease by the use of tolerant varieties, cultural and hygienic 
measures, as well as chemical and biological insect vector control (16, 37). However, 
existing disease control methods are often only partially successful, and in the case of 
systemic insecticides used to control vector populations, may be potentially harmful to 
the environment (41-42).  
Given the current limited success in controlling X. fastidiosa, and the risk of its 
spread, there is a need for the development of an effective and environmentally friendly 
X. fastidiosa control strategy. Recently, there has been renewed interest in the 
application of phage for the control of bacterial plant disease (43). Phages have many 
attractions for both prophylactic and therapeutic control of bacterial plant diseases.  
Phages are self-replicating and self-limiting, specific to target bacteria and can be 
targeted against bacterial receptors that are essential for pathogenesis, without posing 
any harmful effects to plants, animals, humans or associated beneficial microflora.  
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Recently, the first temperate (lysogenic) phage of X. fastidiosa, Xfas53, was  
isolated and characterized (115). However, temperate phage should not be used as 
biocontrol agents because of the potential risk of lysogenic conversion, superinfection 
immunity, and the increased risk of generalized transduction. Virulent (lytic) phages are 
needed for an effective and sustainable phage-based control strategy (114). Here it is 
described the isolation of phages for the plant pathogen X. fastidiosa and the further 
characterization of Xfas103, Xfas106, Xfas303, and Xfas304. 
Materials and methods 
Bacterial strains and culture conditions  
Bacterial strains and plasmids used in this study are listed in TABLE 2. X. 
fastidiosa strains were cultured at 28°C in PW-M broth (PW-MB) (25) or PW-M agar 
plates [PW-MA; PW-MB amended with 20 g/liter plant cell culture tested agar (Sigma)] 
(115). PW-M soft agar (PW-MSA, PW-MB amended with 7.5 g/liter plant cell culture 
tested agar) was used for overlays. Xanthomonas strains were cultured at 28°C in 
tryptone nutrient broth (TNB) (116) or tryptone nutrient agar (TNA; TNB lacking KNO3 
and amended with 20 g/liter agar). TNA soft agar (TNSA, TNB lacking KNO3 and 
amended with 7.5 g/liter agar) was used for overlays. Plant extracts were plated to PW-
MA or TNA amended with cycloheximide (40 µg/ml), designated PW-MC or TNAC, 
for the detection of X. fastidiosa or enumeration and isolation of resident bacteria, 
respectively.  
 
  
 
TABLE 2 Bacterial strains used in this study 
Strain or plasmid  
Genotype and relevant features a 
 
Reference or source 
X. fastidiosa   
    Temecula1 PD strain (subsp. fastidiosa) (ATCC 700964) (12) 
    Ann-1 Oleander isolate (subsp. sandyi) (ATCC 700598) (117) 
    Dixon Almond isolate (subsp. multiplex) (ATCC 700965) (117) 
    XF53 Grape isolate (subsp. fastidiosa) (115) 
    XF54 Grape isolate (subsp. fastidiosa) (115) 
    XF95 Oleander isolate (subsp. sandyi) (115) 
    XF134 Grape isolate (subsp. fastidiosa) This study 
    XF136 Grape isolate (subsp. fastidiosa) This study 
    XF140 Grape isolate (subsp. fastidiosa) This study 
    XF141 Grape isolate (subsp. fastidiosa) This study 
Xanthomonas   
    EC-12 Xanthomonas sp., rice isolate This study 
    North 40 X. axonopodis pv. citri, sweet orange isolate (N. Wang, U. Florida) 
    Ft. Basinger X. axonopodis pv. citri, sweet orange isolate (N. Wang, U. Florida) 
    Block 22 X. axonopodis pv. citri, sweet orange isolate (N. Wang, U. Florida) 
    Jal-4 X. euvesicatoria, jalapeno isolate Laboratory stock 
    Presidio-4 Xanthomonas sp., rice isolate Laboratory stock 
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 Bacteriophage isolation and purification 
Plant and sewage samples were assayed for the presence of phage able to form 
plaques on X. fastidiosa strain Temecula. Plant extracts were prepared by macerating 10 
g of plant tissue (Oryzae sativa or weeds obtained from rice fields in Jefferson County 
and Wharton County, Texas) in 50 ml of P-buffer (50 mM Tris-HCl pH 7.5, 100 mM 
NaCl, 8 mM MgSO4) using a mortar and pestle, strained through a sterile double layer 
of cheese cloth to remove large particles, and filter sterilized. Sewage influent collected 
from a municipal wastewater treatment plant in Brazos County, TX was centrifuged 
twice and filter sterilized. Plant and sewage filtrates were directly screened for phage 
activity using the spot-test and soft agar overlay method (115). Soft agar overlays 
containing 100 µl of strain Temecula (~108 CFU/ml) as an indicator host were allowed 
to solidify, spotted with 10 µl drops of serially diluted filtrates in P-buffer, and assayed 
after incubation at 28ºC for 5-7 days. Filtrates producing either plaques or cleared zones 
were serially diluted in P-buffer and assayed using the overlay method, where 100-µl of 
each dilution was directly mixed with the host suspension in tempered soft agar before 
overlaying.  Individual plaques formed on overlays of strain Temecula were excised, 
suspended in P-buffer, filter sterilized and titered. This procedure was repeated three 
times to obtain single plaque isolates. Additionally, sewage filtrates were screened for 
phage activity using Xanthomonas strain EC-12 (isolated from plant sample, see below), 
as described above. Plaques were purified three times using strain EC-12, and purified 
phages were tested for activity on strain Temecula.  
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 High-titer phage lysates (>1 ൈ 1010 PFU/ml) were prepared by harvesting overlay 
plates of strain Temecula or EC-12 exhibiting confluent lysis with 5 ml of P-buffer, 
macerating the soft agar overlay, clarifying by centrifugation and filter sterilization. 
Lysates were stored at 4 ºC. High-titer phage lysates were further purified by CsCl 
buoyant density centrifugation as previously described (115). 
Bacterial isolation, purification and identification 
Non-filtered plant extracts and sewage samples were plated to PW-MC or 
TNAC, incubated at 28ºC and evaluated for growth (72 h on TNAC and 10 days on PW-
MC). Representative single colonies were picked from plates and streak purified three 
times to obtain stocks on appropriate media. The identification of suspected 
Xanthomonas species was accomplished using the MIDI Sherlock® Microbial 
Identification System (Texas A&M University Plant Disease Clinic) and 16S-23S ITS 
region sequencing using primers Xan16-23F (5’-CTGAGCCAGGATCAAACTCT TC-
3’), Xan16-23R (5’-CCTGACCTATCAACCACGTAGT-3’) and Xan16SF1 (5’-
AAGGAG GTGATCCAGCCGCA-3’). The genome of one Xanthomonas isolate, EC-
12, was sequenced using the 454 pyrosequencing method. Additionally, samples were 
tested for the presence of X. fastidiosa using quantitative real time polymerase chain 
reaction (qRT-PCR) with X. fastidiosa specific primers (INF2 and INR1) as previously 
described (118). 
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 Transmission electron microscopy 
Electron microscopy of CsCl purified phage (~1 ൈ1011 PFU/ml) was performed 
by diluting stock with P-buffer. Phage were applied to thin 400-mesh carbon-coated 
Formvar grids, stained with 2% (wt/vol) uranyl acetate and air dried. Specimens were 
observed on a JEOL 1200EX transmission electron microscope operating at an 
acceleration voltage of 100 kV. Five virions of each phage were measured to calculate 
mean values and standard deviations for dimensions of capsid and tail, where 
appropriate. 
Host range and efficiency of plating 
Host ranges of purified phages (propagated on strain Temecula) were determined 
by the serial dilution spot-test method, as described above, using a panel of X. fastidiosa 
and Xanthomonas isolates as indicator hosts. Efficiency of plating (EOP) was 
determined by calculating the ratio of the phage plaque titer obtained with the 
heterologous (non-propagating) host, to that obtained on the homologous (propagating) 
host (in triplicate). Phage stocks were titered by the soft agar overlay method on either 
strain Temecula or EC-12, as described above.  
One-step growth curve 
Liquid cultures of logarithmically growing strain EC-12 were infected with 
individual phages at a multiplicity of infection (MOI) of ~3, incubated at room 
temperature for 5 min, and then diluted 1000-fold in TNB. Samples were kept at 28oC 
with constant shaking (150 rpm). Two samples were taken at 3 min intervals. One 
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 sample was filter sterilized and plated immediately without any treatment and the other 
was plated after treatment with 1% (vol/vol) chloroform (to release intracellular phages). 
Bacteriophage adsorption 
The kinetics of phage adsorption was determined as previously described (115). 
Liquid cultures of logarithmically growing cells (strain Temecula or EC-12) were 
infected with individual phages (propagated on homologous hosts) at a MOI of ~0.1. 
The mixture was incubated at room temperature with shaking (150 RPM). Samples were 
taken (2 h intervals for strain Temecula and 2 min intervals for strain EC-12), 
immediately filter sterilized, and titered. The rate of phage particle disappearance is 
defined as dP/dt –kBP, where B is the concentration of bacteria, P is the concentration of 
free phage at any time (t), and k is the adsorption constant in ml cell-1 min-1 (119). 
Lysogen formation assay  
To assay for phage lysogens, Temecula and EC-12 spontaneous phage resistant 
mutants were isolated from soft agar overlays of bacteria mixed with Xfas phage 
(individually) at a high MOI (~3). Plates were monitored for cell growth (10-15 days for 
strain Temecula and 2-3 days for strain EC-12). Individual colonies that emerged were 
picked, purified (in triplicate) and tested for phage sensitivity by the soft agar overlay 
method. Primer pairs specific to Xfas103 primase (5’- AACCTGATCTGGTACGAC-3’ 
and 5’- GGACATTTTTCAGTTCTCTC-3’), Xfas106 primase (5’- 
CAACCTCATCTGGTATGAC-3’ and 5’-GTCTTGGGTAATTTCTTTCT-3’), Xfas303 
helicase (5’- AACTACCTGACAGCGACT-3’ and 5’-CGTACTAGCTTGGCTTCTA-
3’) or Xfas304 helicase (5’- AAGAAGCGTGGTTTGTTTGC-3’ and 5’- 
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 CTACCGGCTTCCCTAACTCC-3’) were used to test for the presence of lysogens in 
phage resistant isolates. Wild type bacterial DNA was used as negative control and wild 
type bacterial DNA spiked with phage DNA served as positive controls.  
Results and discussion 
Phage isolation and characterization 
Several phages were isolated from non-enriched plant and sewage filtrates using 
X. fastidiosa or Xanthomonas hosts and four were chosen for further characterization. 
Non-enriched plant extracts yielded phage titers of ~10 to 1 ൈ 105 PFU/g of tissue when 
plated on strain Temecula. Phages Xfas103 and Xfas303 were isolated from non-
enriched rice panicle tissue and Xfas304 was isolated from non-enriched weed tissue by 
direct spotting on strain Temecula. X. fastidiosa was not detected in either plant extracts 
or sewage (direct plating or qRT-PCR to limits of detection). However, plant extracts 
yielded several Xanthomonas isolates, including Xanthomonas strain EC-12. Based on 
draft genome sequence homology, strain EC-12 most closely resembles X. sacchari 
NCPPB 4393 (ZP_09852963). Direct plating of the non-enriched sewage filtrate showed 
no phage activity on strain Temecula, but had a titer of 1 ൈ 103 PFU/ml when plated on 
strain EC-12. Phage Xfas106 was isolated from non-enriched sewage by direct plating to 
strain EC-12. Subsequent plating of purified Xfas106 formed plaques on strain 
Temecula at a reduced efficiency (see below) and may explain why the phage was not 
initially detected using strain Temecula.  Phages Xfas103, Xfas303 and Xfas304, when 
propagated on strain Temecula, were also able to form plaques on strain EC-12. Phages 
Xfas103, Xfas106, Xfas303 and Xfas304, whether propagated on strain Temecula or 
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EC-12, were able to form plaques on three subspecies of X. fastidiosa and exhibited 
difference in their ability to form plaques on X. fastidiosa or Xanthomonas species 
(TABLE 3). Phages Xfas103 and Xfas106 produced small clear plaques, whereas phages 
Xfas303 and Xfas304 produced large clear plaques on lawns of strains Temecula and 
EC-12 (not shown). The shared ability for all four phages to form plaques on several of 
the same hosts but not others, suggests the presence of a shared primary receptor site 
(see below) recognized between the four phages, with yet unknown alternate secondary 
sites. 
Phages Xfas103 and Xfas106 were found to have siphophage morphology, 
exhibiting capsids of 64 (±2.1) and 64 (±0.8) nm in diameter, with long non-contractile 
tails of 204 (±2.3) and 207 (±4.2) nm in length, respectively (FIG 1A,B respectively). 
Phages Xfas303 and Xfas304 were found to have podophage morphology, exhibiting 
capsids of 69 (±1.4) and 68 (±1.1) nm in diameter, respectively, with short non-
contractile tails (FIG 1C,D respectively). 
 
 
 
   
TABLE 3 Phage host range 
Strain Phage  
 Xfas103 Xfas106 Xfas303 Xfas304 
X. fastidiosa     
    Temecula1 +a + + + 
    Ann-1 + + + + 
    Dixon + + + + 
    XF53 + + + + 
    XF54 + + + + 
    XF95 + + + + 
    XF134 - + + + 
    XF136 - + + - 
    XF140 + + + - 
    XF141 - + + - 
Xanthomonas     
    EC-12 + + + + 
    Jal-4 - - + + 
    Presidio-4 - - + + 
    North 40 - - + - 
    Ft. Basinger - - + - 
    Block 22 - - + - 
   aAbility to form individual plaques. 
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FIG 1 Morphology of phages Xfas103, Xfas106, Xfas303 and Xfas304. Transmission 
electron micrographs show (A) Xfas103, (B) Xfas106, (C) Xfas303 and (D) Xfas304 
CsCl-purified phage particles. Samples were negatively stained with 2% (wt/vol) 
aqueous uranyl acetate. Bars, 100 nm. 
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Efficiency of plating  
Phages Xfas106, Xfas303 and Xfas304 plated efficiently to strain Temecula and 
EC-12 (TABLE 4). However, there was an approximate 2- to 3-log reduction in 
efficiency for phage Xfas103 when plated on Temecula or EC-12, respectively (TABLE 
4). This observation is suggestive of a restriction and modification system working in the 
two hosts.  X. fastidiosa contains type I and type II restriction systems (120) and 
Xanthomonas spp. contain type II restriction systems (121), however no experimental 
information on the efficiency is available in the literature. These data suggest either the 
restriction and modification systems are relatively weak in both hosts, or the phages are 
subverting them, as has been reported in phage T7 (122) 
Phage physiological parameters  
Adsorption rate constants were determined from three replicate experiments using 
either strain Temecula or EC-12 as host. The observed rate constant for adsorption to  
 
 
  
   
 
TABLE 4 Influence of bacterial host on efficiency of plating (EOP) 
  Phage isolate 
Production 
host 
Indicator host Xfas103 Xfas106 Xfas303 Xfas304 
Temecula Temecula 1.0 1.0 1.0 1.0 
Temecula EC-12 (1.2 ± 0.2) ൈ 10-2 (1.4 ± 0.5) ൈ 10-1 (2.3 ± 0.2) ൈ 10-3 (3.1 ± 0.3) ൈ 10-1 
EC-12 EC-12 1.0 1.0 1.0 1.0 
EC-12 Temecula (1.4 ± 0.7) ൈ 10-3 (2.0 ± 0.2) ൈ 10-1 (9.5 ± 0.5) ൈ 10-2 (3.2 ± 0.3) ൈ 10-1 
  a Data shown are the means of triplicate independent experiments ± SD. 
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 Temecula for all phages propagated on Temecula was (4.33 ± 0.28) ൈ 10-12 ml cell-1 
min-1, similar to that determined for temperate phage Xfas53 (115). The determined rate 
constants on strain EC-12 for EC-12 propagated phage were (5.48 ± 0.23) ൈ 10-10, (4.58 
± 0.30) ൈ 10-10, (7.26 ± 0.42) ൈ 10-10 and (5.98 ± 0.37) ൈ 10-10 ml cell-1 min-1, for 
Xfas103, Xfas106, Xfas303 and Xfas304, respectively. The observed difference in 
adsorption rates between hosts may be due to bacterial physiological characteristics that 
affect phage receptor site availability and function. An average burst size of 100, 113, 
99, and 104 PFU/cell at ~52 min post infection was determined for phages Xfas103, 
Xfas106, Xfas303 and Xfas304, respectively, using strain EC-12 as host. The extremely 
slow phage adsorption rate to strain Temecula made it experimentally unfeasible to 
determine phage burst size in this host. 
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 CHAPTER III 
COMPLETE GENOME SEQUENCE OF PHAGES FOR Xylella fastidiosa 
 
Introduction 
The study of phage genomics is a fast growing science. Just 10 years ago, there 
were only 150 phage genomes deposited (123). Today there are over 1,000 phage 
genomes  in the database. Comparative genome analysis reveals the evolutionary 
relatedness between phages, particularly those that may appear unrelated at first glance. 
Phages have evolved through horizontal gene transfer events between non homologous 
ancestral sequences, evident from the extreme genetic mosaicism found in phages (123). 
For responsible phage therapy, a phage genome sequence must be known. Genomic 
analysis provides unparalleled, high density information on a new phage. More than 
96% of known phages are “tailed phages” with a linear, dsDNA genome packaged into 
an icosahedral or elongated icosahedral head. A "typical" genome is about 50 kb 
encoding ~ 60 proteins.  Most of the proteins are involved in one of the following 
functional categories- head assembly, tail assembly, lysogenic/lytic decision and 
integration (if temperate), lysis, gene expression, DNA replication, DNA modification, 
host modification or DNA packaging.  An integral approach in phage genomics is 
comparative analysis to known phages (123). However, often greater than 80% of 
predicted genes in a newly sequenced phage are unique to that phage or share homology 
only to a few hypothetical open reading frames (ORFs) in bacteria or other phages (56). 
Genomic analysis allows for rapid classification of some phages into known groups, and 
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 allows for a more complete understanding of a phage’s lifestyle and potential for general 
transduction (114).  Here is described the genome sequence, characteristics and lifestyle 
of phages Xfas103, Xfas106, Xfas303 and Xfas304. 
Materials and methods 
DNA isolation and genome sequencing 
DNA was isolated from CsCl purified phage suspensions as previously described 
(124). Phages Xfas103, Xfas106, Xfas303 and Xfas306 were sequenced as part of two 
pools of phage genomes using the 454 pyrosequencing method (Emory GRA Genomics 
Core). Phage genomic DNA was prepared from phage isolates as described above and 
mixed in equimolar amounts to a final concentration of ca. 100 ng/µl.  The pooled DNA 
was sheared, ligated with a multiplex identifier (MID) tag specific for each of the four 
pools and sequenced by pyrosequencing using a full-plate reaction on a Roche FLX 
Titanium sequencer according to the manufacturer’s protocols. The pooled phage DNA 
was present in two sequencing reactions. The trimmed FLX Titanium flowgram outputs 
corresponding to each of the four pools were assembled individually using the Newbler 
assembler version 2.5.3 (454 Life Sciences) by adjusting settings to include only reads 
containing a single MID identifier per assembly. The identity of individual contigs was 
determined by PCR using primers generated against contig sequences and individual 
phage genomic DNA preparations as template; the generation of the expected size 
product from a phage DNA template was used to match individual phages to their 
contigs. Phage Xfas103 was sequenced to 41-fold coverage, Xfas106 to 62-fold 
coverage, Xfas303 to 140-fold coverage and Xfas304 to 46–fold coverage. Sequencher 
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 4.8 (Gene Codes Corporation) was used for sequence assembly and editing. Phage 
chromosomal end structures were determined as previously described (124).  
ORF prediction and annotation 
Protein-coding regions were initially predicted using GeneMark.hmm (125), 
refined by manual analysis in Artemis (126), and analyzed using BLAST (127). Proteins 
of particular interest were additionally analyzed by InterProScan (128), HHpred searches 
against the pdb70_29jun13 database (129), NCBI's Conserved Domain Database (130), 
LipoP (131), SignalP 4.1 (132), and TMHMM (133). 
Lysogen formation assay  
Xanthomonas strain EC-12 (see chapter II) was cultured at 28°C  in medium  
TNB or TNA as described in Chapter 2.  TNA soft agar (see Chapter II) was used for 
overlays.  Xylella strain Temecula was cultured in medium PW-M or PW-MA as 
described in Chapter II. PW-M-soft agar (see Chapter II) was used for overlays.  To 
assay for phage lysogens, Temecula and EC-12 spontaneous phage resistant mutants 
were isolated from soft agar overlays of bacteria mixed with Xfas phage (individually) at 
a high MOI (~3). Plates were monitored for cell growth (10-15 days for strain Temecula 
and 2-3 days for strain EC-12). Individual colonies that emerged were picked, purified 
(in triplicate) and tested for phage sensitivity by the soft agar overlay method. Primer 
pairs specific to Xfas103 primase (5’- AACCTGATCTGGTACGAC-3’ and 5’- 
GGACATTTTTCAGTTCTCTC-3’), Xfas106 primase (5’- 
CAACCTCATCTGGTATGAC-3’ and 5’-GTCTTGGGTAATTTCTTTCT-3’), Xfas303 
helicase (5’- AACTACCTGACAGCGACT-3’ and 5’-CGTACTAGCTTGGCTTCTA-
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 3’) or Xfas304 helicase (5’- AAGAAGCGTGGTTTGTTTGC-3’ and 5’- 
CTACCGGCTTCCCTAACTCC-3’) were used to test for the presence of lysogens in 
phage resistant isolates. Wild type bacterial DNA was used as a negative control and 
wild type bacterial DNA spiked with phage DNA served as a positive control.  
To examine possible phage repression under high-MOI conditions, we followed 
the procedure of Gill et al. (134). Overnight cultures of strain EC-12 were subcultured 
1:50 into fresh TNB and cultured with aeration at 28°C to an OD600 of 0.3 to 0.5. Cells 
were pelleted by centrifugation and resuspended in 0.20 ml of phage lysate (harvested in 
TNB) or sterile TNB to a final OD600 of 1.0. The cell-phage mixtures were incubated 
for 30 min at 25°C and then centrifuged. Supernatants were removed and an aliquot 
(from the phage mixture) was serially diluted and plated to lawns of EC-12 to determine 
the phage titer remaining after initial incubation. To remove any reversibly bound phage, 
the cell pellets were resuspended in 0.20 ml of sterile TNB and were incubated for an 
additional 10 min at 25°C and then centrifuged. The supernatants were removed and an 
aliquot (from the phage mixture) was serially diluted and plated to lawns of EC-12 to 
determine the phage titer of unbound phage remaining post-incubation. The cell pellets 
were resuspended in 0.20 ml of sterile TNB, serially diluted and plated to enumerate the 
bacterial survivors remaining following phage exposure. The number of surviving CFU 
was compared to the CFU contained in the TNB-only control reaction mixtures to 
calculate the percentage of bacterial survivors. The post-incubation supernatant titers 
(initial and secondary) were compared to the titer of the phage stock to calculate the 
percentage of phage adsorbed to cells during the incubation period. The MOIactual (135) 
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 was calculated as the ratio of the number of adsorbed phage to the number of CFU in the 
phage-free controls. The MOIactual values were used to calculate the proportions of 
cells adsorbing no phage, a single phage, and multiple phage based on a Poisson 
distribution (136). Three independent experiments were conducted using phages 
Xfas103 or Xfas303 with host strain EC-12. 
Results and discussion 
Phages Xfas103 and Xfas106 for X. fastidiosa 
Nucleotide sequence and general sequence properties 
The genomes of Xfas103 and Xfas106 were sequenced to completion by 454 
pyrosequencing and genomic termini were determined experimentally. The general 
characteristics of the phage genomes are summarized in TABLE 5 and complete 
annotations with supporting evidence are provided in TABLE 6. The genomes of 
Xfas103 and Xfas106 were found to be approximately 56.1 and 55.6 kb, encoding 77 
and 72 genes, respectively. It was experimentally determined that the genomes of 
Xfas103 and Xfas106 contain identical 12 bp (GTCAGCGCCCCC) 5’-protruding 
single-stranded cohesive (cos) ends.  Head full packaging is not observed in phages with 
cohesive ends (e.g., phage lambda), indicating that is it unlikely Xfas103 and Xfas106 
are capable of generalized transduction (137-138). 
When analyzed by pairwise DNA MegaBLAST, the genomes of phages Xfas103 
and Xfas106 can be aligned over 69.3% of their length, with an average 80.1% sequence  
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TABLE 5 General features of Xfas103, Xfas106, Xfas303 and Xfas304 genomes 
 Phage  
Feature Xfas103 Xfas106 Xfas303 Xfas304 
Genome size (bp) 56,147 55,601 43,324 43,869 
GC content (%) 62.3 63.0 65.3 60.2 
Predicted No. of genes  77 72 52 51 
Coding density (%) 95.4 96.9 96.0 93.9 
Genomic terminib 5’-overhang 5’-overhang DTR DTR 
 
 
 
  
 
TABLE 6 Comparative annotations of Xylella phages Xfas103 and Xfas106a 
Gene(s) % protein identityb Strand
c Size (kDa) Putative function BcepNazgul homolog locus tagd Evidence
e 
103gp01,  106gp01 52.2 R 10.2, 9.9 Hypothetical novel   
103gp02,  106gp02  R 7.1, 17.5 Hypothetical novel   
103gp03,  106gp03  R 7.2, 36.8 Hypothetical novel   
103gp04,  106gp04  R 13.1, 18.6 Hypothetical novel   
103gp05,  106gp05  R 5.0, 15.8 Hypothetical novel   
103gp06   R 7.3 Hypothetical novel   
103gp07   R 6.8 Hypothetical novel   
103gp08   R 20.3 Conserved protein   
103gp09,  106gp06 50.1 R 27.9, 22.2 Conserved protein   
 106gp07  R 5.4 Hypothetical novel   
103gp10   R 5.3 Hypothetical novel   
103gp11,  106gp08 21.4 R 7.3, 6.8 Hypothetical novel   
 106gp09  F 5.2 Hypothetical novel   
 106gp10  F 3.9 Hypothetical novel   
103gp12   R 19.6 Hypothetical novel   
103gp13,  106gp11 57.1 F 14.7, 15.1 Hypothetical novel   
103gp14,  106gp12 46.0 F 19.1, 20.0 Hypothetical novel   
103gp15,  106gp13 31.0 F 66.8, 61.9 Hypothetical novel   
 106gp14  F 9.5 Hypothetical novel   
103gp16,  106gp15 66.2 F 8.7, 9.2 Hypothetical novel   
103gp17,  106gp16 36.5 F 17.9, 19.2 Hypothetical novel   
103gp18,  106gp17 89.1 F 11.9, 12.0 Conserved protein   
103gp19,  106gp18 79.8 F 10.8, 10.8 Hypothetical novel   
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TABLE 6 Continued, 
Gene(s) % protein identityb Strand
c Size (kDa) Putative function BcepNazgul homolog locus tagd Evidence
e 
103gp20   F 19.6 Hypothetical novel   
103gp21   F 6.5 Hypothetical novel   
103gp22,  106gp19 93.6 F 11.6, 11.7 Hypothetical novel   
103gp23,  106gp20 68.5 F 22.0, 23.1 Hypothetical novel   
103gp24   F 5.9 Hypothetical novel   
103gp25,  106gp21 56.5 F 11.8, 11.8 Hypothetical novel   
103gp26,  106gp22 70.3 F 8.2, 9.3 Hypothetical novel   
103gp27,  106gp23 34.1 F 12.4, 15.2 Hypothetical novel   
103gp28,  106gp24 68.4 F 26.3, 26.6 Conserved protein NP_918968.1(E=1.24E-
09, Dice=19.3) 
 
103gp29,  106gp25 52.1 F 16.0, 14.8 Hypothetical novel   
103gp30,  106gp26 49.4 F 19.5, 18.0 Hypothetical novel   
103gp31,  106gp27 57.6 F 24.8, 25.5 Hypothetical novel   
103gp32,  106gp28 12.8 F 10.2, 10.3 Hypothetical novel   
103gp33,  106gp29 62.5 F 21.9, 22.1 Hypothetical novel   
103gp34,  106gp30 76.9 F 17.0, 17.0 Conserved protein  IPR012816, 
PF08719, 
TIGR02464, 
SSF143990 
 106gp31  F 12.7 Hypothetical novel   
103gp35,  106gp32 53.1 F 27.1, 27.7 Conserved protein  SSF52374, 
SSF52540, 
(PF13207, Xfas103 
only) (IPR002891, 
PF01583 Xfas106 
only)  
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TABLE 6 Continued, 
Gene(s) % protein identityb Strand
c Size (kDa) Putative function BcepNazgul homolog locus tagd Evidence
e 
103gp36   F 11.4 Hypothetical novel   
103gp37,  106gp33 75.9 F 34.1, 34.2 Conserved protein  (IPR002815, 
SSF56726, Xfas106 
only) 
103gp38   F 9.7 Hypothetical novel   
103gp39,  106gp34 30.1 R 11.2, 13.5 Rz1  (Lipoprotein 
adjacent to inner 
membrane spanin 
component, Xfas103 
only) (lipoprotein 
overlapped with 
inner membrane 
spanin component, 
Xfas106 only) 
103gp40,  106gp35 31.7 R 13.6, 15.4 Rz  N-terminal TMD 
103gp41,  106gp38  R 17.7, 28.6 Putative antiholin  Predicted 1 TMD 
103gp42,  106gp37  R 15.8, 16.3 Holin  (Predicted 4 TMDs, 
Xfas103 only) 
(predicted 2 TMDs, 
Xfas106 only) 
103gp43,  106gp36  R 21.3, 31.5 Endolysin  (IPR024408, 
PF11860, HHpred 
hit 3gxr_A prob 
97.7% E=4E-05, 
Xfas103 only) 
(LipoP, SignalP, 
HHpred hit 2anv_A 
prob 100% E=3E-37, 
Xfas106 only) 
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TABLE 6 Continued, 
Gene(s) % protein identityb Strand
c Size (kDa) Putative function BcepNazgul homolog locus tagd Evidence
e 
103gp44,  106gp39 46.0 R 37.4, 38.5 Tail fiber protein  (IPR001791, 
SM00282, Xfas103 
only) IPR008985, 
SSF49899, PF13385, 
Positional evidence, 
see text 
103gp45,  106gp40 72.8 R 34.8, 35.2 Conserved tail 
assembly protein 
 Positional evidence, 
see text 
103gp46,  106gp41 85.7 R 6.3, 6.3 Conserved tail 
assembly protein 
 Positional evidence, 
see text 
103gp47,  106gp42 83.9 R 27.2, 27.0 Conserved tail 
assembly protein 
 Positional evidence, 
see text 
103gp48,  106gp43 75.2 R 90.7, 89.5 Conserved tail 
assembly protein 
NP_918976.1 (E=1.45E-
60, Dice=25.0) 
PF13550, positional 
evidence, see text 
103gp49,  106gp44 78.0 R 30.4, 30.3 Conserved tail 
assembly protein 
NP_918979.1 (E=8.65E-
18, Dice=26.0) 
IPR018964, 
PF09356, 
IPR019228, 
PF09931, Positional 
evidence, see text 
103gp50,  106gp45 75.1 R 64.0, 63.4 Conserved tail 
assembly protein 
NP_918980.1(E=1.79E-
13, Dice=11.5)  
Positional evidence, 
see text  
103gp51,  106gp46 72.5 R 33.2, 33.0 Conserved tail 
assembly protein 
 Positional evidence, 
see text 
103gp52,  106gp47 80.8 R 36.4, 36.7 Conserved tail 
assembly protein 
 Positional evidence, 
see text  
103gp53,  106gp48 77.1 R 156.6, 156.3 Tape measure protein   IPR013491, 
TIGR02675 
103gp54,  106gp49 67.8 R 25.6, 25.7 Pre-tape measure 
frameshift protein GT 
NP_918998.2(E=6.45E-
21, Dice=27.0) 
Positional evidence, 
see text 
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TABLE 6 Continued, 
Gene(s) % protein identityb Strand
c Size (kDa) Putative function BcepNazgul homolog locus tagd Evidence
e 
103gp55,  106gp50 63.2 R 18.6, 18.1 Pre-tape measure 
frameshift protein G  
NP_918998.2(E=4.52E-
04, Dice=16.1) 
Positional evidence, 
see text, slippery 
sequence 5’-
GGGAAAC-3’ 
103gp56,  106gp51 79.2 R 28.4, 28.7 Conserved, virion 
associated protein 
NP_918986.1(E=8.77E-
63, Dice=42.6) 
 
103gp57,  106gp52 78.9 R 19.2, 18.8 Conserved, virion 
associated protein 
NP_918987.2(E=8.60E-
22, Dice=30.6) 
 
103gp58,  106gp53 79.3 R 22.5, 22.8 Conserved protein NP_918988.2(E=7.56E-
32, Dice=38.9) 
 
103gp59,  106gp54 61.7 R 13.0, 12.6 Conserved protein NP_918989.2(E=2.26E-
20, Dice=32.3) 
 
103gp60,  106gp55 55.7 R 10.4, 9.8 Conserved protein   
103gp61,  106gp56 90.3 R 38.3, 38.5 Major capsid protein  NP_918991.1(E=1.81E-
86, Dice=42.0) 
IPR005564, 
PF03864 
103gp62,  106gp57 75.4 R 14.2, 13.8 Decorator protein  NP_918992.1(E=1.72E-
14, Dice= 28.9) 
IPR004195, 
PF02924 
103gp63,  106gp58 66.7 R 14.6, 15.0 Scaffold  NP_918993.2(E=4.01E-
15, Dice=32.3) 
 
103gp64,  106gp59 75.2 R 47.8, 47.9 Prohead protease  NP_918994.2(E=1.36E-
90, Dice=38.2) 
IPR002142, 
PF01343, 
PTHR32497, 
SSF52096 
103gp65,  106gp60 83.6 R 62.1, 61.6 Portal protein  NP_918995.1(E=3.37E-
168, Dice=45.7) 
IPR006429, 
PF05136, 
TIGR01539 
103gp66,  106gp61 78.1 R 8.0, 8.1 Head-to-tail joining 
protein  
NP_918996.1(E=2.70E-
12, Dice=29.1) 
IPR004174, 
PF02831, SSF64210 
103gp67,  106gp62 83.6 R 80.4, 79.2 TerL NP_918997.2(E=0, 
Dice=48.3) 
IPR008866, 
PF05876 
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TABLE 6 Continued, 
Gene(s) % protein identityb Strand
c Size (kDa) Putative function BcepNazgul homolog locus tagd Evidence
e 
103gp68,  106gp63 82.0 R 22.0, 22.4 TerS  NP_918999.1(E=4.62E-
43, Dice=30.4) 
IPR009901, 
PF07278 
103gp69,  106gp64 78.3 R 54.2, 53.9 Helicase NP_919000.2(E=9.34E-
66, Dice=29.3) 
IPR000330, 
PF00176, 
IPR014001, 
SM00487, 
SSF52540 
103gp70,  106gp65 77.2 R 11.7, 13.7 Holliday-junction 
resolvase  
NP_919001.2(E=3.75E-
18, Dice=30.8) 
IPR014883, 
PF08774, SM00990 
103gp71,  106gp66 78.6 R 79.1, 77.8 DNA polymerase I  NP_919002.1(E=6.40E-
167, Dice=40.2) 
IPR001098, 
PF00476, SM00482, 
SSF56672 
103gp72,  106gp67 44.0 R 31.1, 30.3 Putative ligase NP_919004.1(E=4.38E-
25, Dice=25.4) 
IPR012340, 
SSF50249, 
IPR022595, 
PF10991 
103gp73,  106gp68 73.7 R 46.6, 44.9 Conserved protein NP_919005.2(E=7.93E-
59, Dice=27.9) 
IPR021229, 
PF10926 
103gp74,  106gp69 53.8 R 16.7, 16.5 Putative lipoprotein  LipoP 
103gp75,  106gp70 86.0 F 10.3, 12.2 Hypothetical novel   
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TABLE 6 Continued, 
Gene(s) % protein identityb Strand
c Size (kDa) Putative function BcepNazgul homolog locus tagd Evidence
e 
103gp76,  106gp71 80.5 F 95.5, 95.5 DNA primase  NP_919008.2(E=1.27E-
158, Dice=33.0) 
IPR014819, 
PF08707, 
IPR015330, 
PF09250, SM00943, 
SSF52540, 
SSF56747 
103gp77,  106gp72 52.6 F 10.5, 11.6 Hypothetical novel   
a Putative assignable functions and protein molecular masses are shown.  
b Protein identities between Xfas103 and Xfas106 homologs were calculated by the Dice method using BLASTp alignment 
identity scores. 
c  F/R, coding region on forward or reverse strand, respectively. 
d E value and Dice identity reported  for phage BcepNazgul homologs in Xfas103.  
e Evidence includes detected conserved domains or motifs, HHpred hits, or other evidence as detailed in the text. 
 
  
 
FIG 2 Synteny of phages Xfas103 and Xfas106 as compared to Burkholderia phage BcepNazgul, Burkholderia phage AH2, Enterobacter phage Enc34, Escherichia phage Chi and Providencia phage Redjac.
connected by solid lines. Similarity at the amino acid level between homologous genes of Xfas303 and Xfas304 are indicated by color: white, <20%; green, 20-39.9%; yellow, 40-59.9%; orange, 60-79.9%; re
green, head protein; turquoise green, tail protein; purple, DNA metabolism. 
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 identity in aligned regions. Xfas103 and Xfas106 contain 58 homologous genes with 
amino acid sequence similarities ranging from 12.8% to 93.6%, and have retained 
genome synteny (TABLE 6, FIG 2). Although there is no direct evidence of 
transcriptional boundaries, there are few breaks in coding sequence large enough to 
contain promoters and there are no detected terminators, thus the simplest interpretation 
is that the genomes are organized into four divergent transcriptional units based on 
coding strand position. Genes found in transcriptional unit one (starting at the left end, 
reverse strand) and two (forward strand) primarily encode proteins of unknown function 
and show very limited similarity to other phage genes in the NCBI nr database. The lysis 
cassette, structural module and DNA metabolism module are all encoded for in 
transcriptional unit three (reverse strand), whereas transcriptional unit four (forward 
strand) encodes only a few genes, including a predicted primase. 
When analyzed by BLASTp, Xfas103 and Xfas106 are most closely related to 
Burkholderia phage BcepNazgul (NC_005091); however, the relationship is distant. Of 
the 77 predicted Xfas103 genes, only 23 show homology to BcepNazgul, ranging from 
11.0%-48.2% sequence identity at the amino acid level. These genes are primarily 
located in the structural and DNA metabolism regions (excluding tail fiber and assembly 
proteins). Despite the low observed homology, phages Xfas103 and Xfas106 are largely 
syntenic with BcepNazgul (FIG 2).  
As previously noted by Gill et al.(56), the assignment of phage groups based on 
protein or DNA sequence relationships, without regard to overall genome architecture, 
results in numerous phage groups with no obvious evolutionary linkage to each other. 
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 Casjens et al. (139) have proposed a “phage type” model that groups phages based on 
shared features of genome organization and relatedness of genes. BcepNazgul does not 
belong to any existing phage types because of its unique architecture and low homology 
to previously described phages. We therefore propose that BcepNazgul is the founder of 
a new phage type, as defined by Casjens, to which both Xfas103 and Xfas106 belong. 
Further analysis and reannotation of the genomes of Burkholderia phage AH2, 
Enterobacter phage Enc34, Escherichia phage Chi and Providencia phage Redjac 
indicate they are BcepNazgul-like phages (FIG 2). Another factor that must be taken into 
consideration when classifying phage type is lifestyle. Phage Enc34 has been reported to 
be virulent (140), whereas there is no report of the phage lifestyle of Chi and Redjac 
(141-142). Phage AH2 was not defined by the authors as temperate (139), but there is 
clearly evidence that it may be a temperate phage (addressed below). 
Gene organization and homology 
In the following, except where significant differences exist between Xfas103 and 
Xfas106, only the relationship between Xfas103 proteins and database homologs will be 
discussed in detail (FIG 2, TABLE 6).  
Transcriptional units one and two 
Most proteins encoded in transcriptional units one and two do not have phage 
homologs in the database. Despite this, 24 of the 38 proteins encoded in Xfas103 
transcriptional units one and two have homologs in Xfas106, with 12.8% to 93.6% 
sequence identity at the amino acid level (FIG 2, TABLE 6). Only one protein (Xfas103 
gp28) has a homolog in phage BcepNazgul (BcepNazgul gp34). 
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 Lysis genes  
Xfas106 and BcepNazgul contain lysis cassettes with the canonical gene order of 
holin-endolysin-Rz/Rz1 (genes Xfas106 34-37 and genes BcepNazgul 36-39, 
respectively), whereas in Xfas103 the holin gene (gp42) is found upstream of the 
endolysin (gp43) (FIG 2).  
Spanins were identified by their unique primary and secondary features. Xfas103 
Rz gp40 is a type II (N-in, C-out) cytoplasmic membrane protein (as predicted by 
TMHMM), and Xfas103 Rz1 gp39 is an OM protein (as predicted by LipoP). The 
Xfas103 spanin complex belongs to the separated spanin class, with overlapping Rz stop 
and Rz1 start codons, as in phage T4. Despite protein homology between the spanin 
components of Xfas103 and Xfas106, Xfas106 Rz (gp35) and Rz1 (gp34) are ordered in 
an overlapped arrangement, as in BcepNazgul (FIG 2). 
Phage endolysins in Xfas103 (gp43) and Xfas106 (gp36) were identified by the 
presence of catalytic motifs and amino acid homology to phage endolysin proteins in the 
database (TABLE 6). The Xfas103 endolysin contains a DUF3380 domain (IPR024408), 
which has been defined as a peptidoglycan binding domain in phage PRD1 (143). 
Xfas106 gp36 is a lipoprotein (based on LipoP), containing a C-terminal lysozyme 
catalytic domain as detected by HHpred (hit 2anv_A, 100% probability), with a weak N-
terminal signal sequence as predicted by SignalP, which suggests gp36 may be a SAR 
endolysin.  
Phage holin genes are extremely diverse, but most have at least one TMD and are 
usually located within the lysis cassette adjacent to the endolysin and spanin genes. 
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 Three experimentally verified holin topologies have been previously been identified: 
class I (3 TMDs with N-out, C-in); class II (2 TMDs with N-in, C-in); class III (one 
TMD with N-in, C-out) (67). Xfas103 gp42 is a putative holin, based on its location 
clustered within the lysis cassette and the presence of multiple TMDs.  Amino acid 
charge analysis of Xfas103 gp42 suggests four strong TMDs with three net-positive 
soluble domains and a negatively charged C-terminal, which represents a novel holin 
membrane topology (FIG 3). Xfas106 gp37 is predicted to encode a class II holin, but 
contains an unusually large total sequence and soluble domains (FIG 3). The 
BcepNazgul holin (gp39) has all the characteristics of a class I holin, including and net-
positive N-terminal and basic C-terminal ends. However, TMD3 contains 13 amino 
acids bound by arginine residues, and is too small to normally be considered a TMD.  
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FIG 3 Primary and topological properties of holin proteins. (A) Primary structures of 
BcepNazgul gp39, Xfas103 gp42, Xfas106 gp37 and AH2 gp43. TMDs are shown in bold 
text, with charged residues indicated above. (B) Topological models of BcepNazgul, 
Xfas103, Xfas106 and AH2 predicted holins. IM: inner membrane. 
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 The last TMD of the class II AH2 holin (gp43) also contains 13 amino acids bound by 
arginine residues (FIG 3). In both cases, the C-terminal TMD is too short and may have 
a kinetic defect in membrane localization. This can lead one to speculate that possibly 
the last TMD in these two otherwise unrelated proteins are kinetically challenged in 
terms of integration and are not inserted into the membrane until the membrane potential 
collapses. This would suggest that topological determinants can force C-terminal TMDs 
in the membrane despite “illegal” R to R spacing, possibly resulting in a new form of 
dynamic topological control of holin function.   
Dual start and non-dual start phage antiholins are utilized by some phages to 
control phage lysis timing (68). Phages Xfas103, Xfas106 and BcepNazgul all have a 
hypothetical protein with 1 TMD was found adjacent (BcepNazgul gp40 and Xfas106 
gp38) or within (Xfas103 gp41) the lysis cassette, and are thus predicted antiholins. 
Structural genes   
There is limited homology between the tail fiber and assembly genes of Xfas103 
genes with BcepNazgul. However, Xfas103 gp44-52 can be presumptively assigned the 
functions of tail fiber and assembly proteins based on synteny to similar genes in 
BcepNazgul (gp41-49). Xfas103 gp44 contains a laminin G domain (IPR001791) and a 
concanavalin A-like lectin/glucanase domain (IPR008985). Laminin G domains are 
associated with binding functions, and several con A-like domains are found in proteins 
involved in cell recognition and adhesion. BcepNazgul tail fiber protein (gp42) has a 
similar galactose-binding domain (IPR008979), which is associated with binding to 
specific ligands such as cell-surface-attached carbohydrate substrates. Xfas103 gp53 is a 
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 predicted phage tape measure protein based on the detection of tape measure domain 
(IPR013491). Xfas103 gp54 and gp55 are predicted to encode frameshift proteins GT 
and G, respectively. A programmed translational frameshift is strongly conserved in tail 
assembly genes of dsDNA phages, and has been shown to be required for proper tail 
morphogenesis (144).  A manual search of G proteins identified the slippery sequence 
5’-GGGAAAC-3’for both Xfas103 and Xfas106.  
Xfas103 head assembly and DNA packaging genes are syntenic and share 
homology to genes in BcepNazgul. Xfas103 encodes homologs of BcepNazgul gp53-56 
(virion associated proteins), gp58 (major capsid), gp59 (decorator), gp60 (scaffold), 
gp61 (prohead protease), gp62 (portal) and gp63 (head-to-tail joining protein), with 
11.0-42.6% sequence identity at the amino acid level. Therefore Xfas103 gp56-59, gp61, 
gp62, gp63, gp64, gp65 and gp66 are predicted to function as virion associated proteins, 
major capsid, decorator, scaffold, prohead protease, portal and head-tail joining protein, 
respectively. The protease and scaffold reading frames are fused, with the scaffold start 
codon downstream within the protease gene, similar to that observed in gpC and gpNu3 
proteins of phage lambda (145). The predicted portal protein (gp65) and head-to-tail 
joining protein (gp66) are members of the phage lambda GpB portal (IPR006429) and 
head-to-tail joining protein W GpW family (IPR004174), respectively.  
Xfas103 large subunit terminase (TerL) and small subunit terminase (TerS) 
proteins were identified by amino acid homology to BcepNazgul homologs gp64 and 
gp65, respectively. The TerL subunit contains all of the catalytic activities required for 
DNA maturation and packaging, whereas the TerS subunit is required for specific 
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 recognition of viral DNA. As in phage lambda, the TerS of BcepNazgul-like phages 
recognize phage cos sites for initiation and termination of DNA packaging, removing the 
risk of generalized phage transduction.  
DNA metabolism and replication  
Xfas103 gp69 is predicted to encode a phage helicase based on homology to the 
BcepNazgul helicase (gp66). Xfas103 gp70 is homologous to BcepNazgul gp67 
(conserved phage protein), and is predicted to be a Holliday-junction resolvase. This 
function is supported by the presence of a VRR-NUC domain (IPR014883) that is 
associated with nuclease activity, and by HHpred predicted similarity to Holliday-
junction resolvases (1hh1_A with 98.5% probability).  Xfas103 gp71 is homologous to 
the BcepNazgul DNA polymerase 1 (gp68), and contains a DNA-directed DNA 
polymerase family A palm domain (IPR001098). Xfas103 gp72 is homologous to 
BcepNazgul gp70, a predicted conserved protein. Both Xfas gp72 and BcepNazgul gp70 
contain a phage APSE-1 protein 50 family domain (IPR022595) and a nucleic acid-
binding OB-fold domain (IPR012340). These domains are found in ATP and NAD-
dependent DNA ligases, indicating that Xfas103 gp72 may be a putative DNA ligase. No 
phage RNA polymerase (RNAP) was identified in Xfas103, indicating that all 
transcription is accomplished by the host RNAP. Xfas103 gp76 is a predicted primase 
based on amino acid homology to BcepNazgul gp74 (primase) and other phage 
homologs. It contains a primase C-terminal 2 (IPR014819) and DNA 
primase/polymerase bifunctional N-terminal domain (IPR015330), and is separated from 
the DNA replication genes in transcriptional unit three. 
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 Phages Xfas303 and Xfas304 for X. fastidiosa 
Nucleotide sequence and general sequence properties 
The genomes of Xfas303 and Xfas304 were sequenced to completion by 454 
pyrosequencing, and genomic termini were determined experimentally. The general 
characteristics of the phage genomes are summarized in TABLE 5 and complete 
annotations with supporting evidence are provided in TABLE 7. The genomes of 
Xfas303 and Xfas304 were found to be approximately 43.3 and 43.8 kb, encoding 52 
and 51 genes, respectively. It was experimentally determined that the genomes of 
Xfas103 and Xfas106 contain non-permutated short direct terminal repeats of 619 and 
675 bp, respectively. 
Analysis indicates that phages Xfas303 and Xfas304 share no significant DNA 
homology when compared by pairwise DNA megaBLAST. Despite extreme DNA 
sequence divergence, Xfas303 and Xfas304 contain 43 homologous genes with amino 
acid similarities ranging from 17.1% to 79.0%, and have retained canonical phiKMV-
like gene order (FIG 4, TABLE 7). Similar to T7-like phages, phiKMV-like phage 
genomes consist of three functional gene clusters. Class I encodes for early genes with 
functions to overcome host restriction and to convert the metabolism of the host cell to  
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the production of phage proteins. Class II encodes for proteins involved in DNA 
metabolism. Class III encodes for structural and assembly proteins, DNA packaging 
proteins and lysis proteins. phiKMV-like phages are distinguished from T7-like phages 
in that they encode for a single subunit RNA polymerase (ssRNAP) at the end of the 
class II gene cluster, rather than in the early genomic region (146).  Sequenced phiKMV-
like phages have been reported for a wide range of hosts, including members of the 
Gamma-protebacteria and Beta-proteobacteria.  
Xfas303 and Xfas304 are clearly phiKMV-like based on genome organization 
and protein homology with other phiKMV-like phages. Of the sequenced phiKMV-like 
phages, Xfas303 is most similar to Caulobacter phage Cd1 (GU393987), with 26 
homologous genes ranging from 7.6-54.8% amino acid similarity.  
 
  
 
FIG 4 Synteny of phages Xfas303 and Xfas304 as compared to Pseudomonas phage phiKMV and Caulobacter phage Cd1. Predicted reading frames are indicated by boxes. Functionally equivalent genes are 
connected by lines. Similarity at the amino acid level of homologous genes between Xfas303 and Xfas304 is indicated by color: white, <20%; green, 20-39.9%; yellow, 40-59.9%; orange, 60-79.9%; red, ≥80%. 
Functional modules are represented by different colors: light blue, lysis; turquoise green, structural protein; purple, DNA metabolism. 
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TABLE 7 Comparative annotations of Xylella phages Xfas303 and Xfas304a 
Gene(s) % protein 
identityb 
Strandc Size 
(kDa) 
Putative function Phage Cd1 homolog 
 locus tagd 
Evidencee 
303gp01,  304gp01 26.9 F 9.2, 10.3 Hypothetical novel   
303gp02,  304gp02 21.2 F 19.7, 
19.6 
Conserved protein ADD21636.1(E=6.68E-07, 
Dice=26.2) 
 
303gp03,  304gp03 21.4 F 18.1, 
16.8 
Conserved protein   
303gp04   F 32.9 Conserved protein   
                304gp04  F 6.6 Hypothetical novel   
303gp05,  304gp05  F 5, 22.2 Hypothetical novel   
303gp06,  304gp06  F 8.2, 13.9 Hypothetical novel   
303gp07,  304gp07  F 19.5, 
21.2 
Hypothetical novel   
303gp08,  304gp08  F 11.3, 
10.8 
Hypothetical novel   
303gp09   F 13.5 Hypothetical novel   
303gp10,   304gp09 24.7 F 12.3, 
15.8 
Hypothetical novel   
303gp11,  304gp10 29.0 F 15, 15.8 Conserved protein ADD21644.1(E=5.10E-08, 
Dice=22.1) 
 
                 304gp11  F 6.9 Hypothetical novel   
303gp12,  304gp12  F 8.1, 11.8 Hypothetical novel   
303gp13,  304gp13 50.5 F 31.1, 
31.8 
DNA primase  ADD21651.1 (E= 9.66E-47, 
Dice=35.0) 
cd01029 
                 304gp14  F 18.1 Hypothetical novel   
303gp14,  304gp15 38.4 F 48.4, 
49.8 
DNA helicase  ADD21652.1 (E=9.62E-109, 
Dice=40.9) 
PF13481, 
(SSF52540 Xfas304 
only) 
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TABLE 7 Continued, 
Gene(s) % protein 
identityb 
Strandc Size 
(kDa) 
Putative function Phage Cd1 homolog 
 locus tagd 
Evidencee 
303gp15,  304gp16 25.3 F 10.6, 
12.3 
Hypothetical novel   
303gp16   F 7.5 Hypothetical novel   
303gp17,  304gp17 51.9 F 92.5, 
88.9 
DNA polymerase A ADD21653.1(E=0, Dice=51.4) IPR001098, 
PF00476, SM00482, 
IPR002298, 
PR00868, 
PTHR10133, 
SSF56672 
303gp18,  304gp18 40.1 F 32.1, 
31.7 
Conserved protein ADD21654.1(E=5.07E-54, 
Dice=35.3) 
 
303gp19,  304gp19 52.1 F 34.4, 
35.1 
5'-3' exonuclease  ADD21655.1(E=2.63E-72, 
Dice=38.5) 
IPR020045,SSF478
07 
303gp20,  304gp20 70.2 F 14.1, 
12.8 
DNA endonuclease 
VII  
ADD21656.1(E=6.39E-34, 
Dice=45.9) 
IPR004211, 
PF02945, SSF54060 
303gp21,  304gp21 79.2 F 31.8, 
32.2 
3' to 5' exonuclease   IPR012337, 
SSF53098 
303gp22,  304gp22 30.3 F 22.1, 
23.7 
Conserved protein   
303gp23,  304gp24 75.2 F 8, 8.1 Conserved protein   
303gp24   F 8.2 Hypothetical novel   
303gp25,  304gp23 20.3 F 11.4, 9.3 Conserved protein   
303gp26,  304gp25 35.0 F 33.3, 
37.6 
ATP-dependent DNA 
ligase  
ADD21659.1(E=2.41E-47, 
Dice=36.3) 
(IPR012310, 
PF01068 Xfas303 
only) IPR012340, 
SSF50249, 
SSF56091; 
303gp27,  304gp26 43.9 F 6.7, 6.4 Hypothetical novel   
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Gene(s) % protein 
identityb 
Strandc Size 
(kDa) 
Putative function Phage Cd1 homolog 
 locus tagd 
Evidencee 
303gp28,  304gp27 56.3 F 95.6, 
91.7 
DNA-dependent  
RNA polymerase  
ADD21661.1(E=0, Dice=51.0)  IPR002092, 
PTHR10102, 
PF00940, SSF56672 
303gp29,  304gp28 26.8 F 7.1, 6.5 Conserved protein ADD21662.1(E=2.80E-06, 
Dice=23.6) 
 
303gp30   F 15.2 Conserved protein ADD21663.1(E=2.42E-16, 
Dice=24.5) 
 
303gp31,  304gp29 30.1 F 12.1, 
11.3 
Conserved protein ADD21664.1(E=3.00E-05, 
Dice=31.1) 
 
303gp32,  304gp30 47.2 F 56.5, 
56.5 
Head -tail connector  ADD21666.1(E=2.43E-154, 
Dice=44.5) 
IPR020991, 
PF12236 
303gp33,  304gp31 22.2 F 28.9, 
26.3 
Scaffold ADD21667.1(E=4.29E-06, 
Dice=18.5) 
(PHA01929 
Xfas303 only) 
303gp34,  304gp32 57.1 F 36.3, 
36.3 
Major capsid protein ADD21668.1(E=2.91E-84, 
Dice=43.2) 
cl18086 
303gp35,  304gp33 19.4 F 7.4, 7.9 Hypothetical novel   
303gp36,  304gp34 33.6 F 23.9, 
24.0 
Tail tubular protein A ADD21669.1(E=4.31E-35, 
Dice=29.3) 
cl10205 
303gp37,  304gp35 42.0 F 91.5, 
93.8 
Tail tubular protein B ADD21670.1(E=0, Dice=36.8)  
303gp38,  304gp36 38.8 F 31.4, 
30.2 
Internal Virion 
protein  
 
ADD21671.1(E=6.34E-21, 
Dice=21.7) 
 
303gp39,  304gp37 28.0 F 85.0, 
85.1 
Internal Virion 
protein  
 
ADD21672.1(E=5.50E-29, 
Dice=12.0) 
 
303gp40,  304gp38 34.4 F 176.3, 
147.1 
Internal Virion 
protein  
with transclycosylase 
activity 
ADD21673.1(E=2.85E-120, 
Dice=18.9) 
IPR023346, 
SSF53955 
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TABLE 7 Continued, 
Gene(s) % protein 
identityb 
Strandc Size 
(kDa) 
Putative function Phage Cd1 homolog 
 locus tagd 
Evidencee 
303gp41,  304gp39 46.0 F 39.8, 
39.7 
Tail fiber protein ADD21674.1(E=1.57E-15, 
Dice=7.6) 
IPR005604, 
PF03906 
303gp42,  304gp40 32.8 F 44, 43.3 Putative tail fiber 
protein 
 See text 
303gp43,  304gp41 24.5 F 33.6, 
34.7 
Putative tail fiber 
protein  
 See text 
303gp44,  304gp42 36.2 F 21.2, 
20.7 
Putative tail fiber 
protein 
 See text 
303gp45,  304gp43 38.2 F 7.3, 7.0 Holin  Predicted 2 TMDs, 
see text 
303gp46,  304gp44 27.7 F 10.1, 
10.2 
TerS ADD21677.1(E=1.80E-05, 
Dice=21.9) 
 
303gp47,  304gp45 59.8 F 65.8, 
65.7 
TerL  ADD21678.1(E=0, Dice=54.9)  
303gp48,  304gp46 41.9 F 8.5, 7.2 Hypothetical novel   
 304gp47  F 29.8 Conserved protein    
303gp49,  304gp48 49.3 F 19.2, 
18.3 
Endolysin ADD21680.1(E=1.52E-25, 
Dice=32.0) 
IPR002196, 
PF00959, 
IPR023346, 
SSF53955 
303gp50,  304gp49 17.1 F 11.2, 
10.8 
Rz  N-terminal TMD 
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Gene(s) % protein 
identityb 
Strandc Size 
(kDa) 
Putative function Phage Cd1 homolog 
 locus tagd 
Evidencee 
303gp51,  304gp50 41.9 F 10.7, 
10.2 
Rz1 ADD21682.1(E=1.25E-05, 
Dice=20.1) 
Lipoprotein 
overlapped with 
inner membrane 
spanin component 
303gp52,  304gp51 39.7 F 15.1, 
14.1 
Conserved protein    
a Putative assignable functions and protein molecular masses are shown.  
b Protein identities between Xfas303 and Xfas304 homologs were calculated by the Dice method using BLASTp alignment 
identity scores. 
c F/R, coding region on forward or reverse strand, respectively. 
d E value and Dice identity reported  for phage Cd1 homologs in Xfas303.  
e Evidence includes detected conserved domains or motifs, HHpred hits, or other evidence as detailed in the text. 
 Gene organization and homology 
In the following, except where significant differences exist between Xfas303 and 
Xfas304, only the relationship between Xfas303 proteins and database homologs will be 
discussed in detail (FIG 4, TABLE 7). 
Early genes  
Early genes are involved in host conversion and have been reported to protect 
phage from bacterial defense mechanisms or alter host cell mechanisms (147).  When 
comparing phages of the same phage type, phage proteins that interact most intimately 
with the bacterial host have been reported to be the most diverse (148). Five out of 12 
Xfas303 early genes have homologs in Xfas304. Only two early genes, Xfas gp02 and 
gp11, have homologs in other phiKMV-like phages, namely Cd1 gp01 and gp09, 
respectively.  
DNA metabolism  
Phage Xfas303 DNA metabolism genes follow the canonical phiKMV-like gene 
order of DNA primase (gp13), DNA helicase (gp14), DNA polymerase A (gp17), 5’-3’ 
exonuclease (gp19), DNA exonuclease VII (gp20), ATP-dependent DNA ligase (gp26), 
and an ssRNAP (gp28) (FIG 4). Xfas303 gp21 and gp22 do not have homologs in Cd1, 
but do have homologs in other phiKMV-like phages, such as Ralstonia phage RSB1 
gp22 and gp24, respectively. The Xfas303 ssRNAP is located at the right end of the 
DNA metabolism gene cluster, a distinguishing characteristic of all reported phiKMV-
like phages. However, it has been noted that the position of the DNA ligase gene can 
vary within phiKMV-like phages (149). In phiKMV, the DNA ligase is encoded at the 
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 beginning of the DNA metabolism genes, whereas in Cd1 the DNA ligase is encoded 
directly before the RNA polymerase. Phage Xfas303 shares the gene order of phage Cd1 
(FIG 4).  
It is of note, that the DNA metabolism region of Xfas303 also shares high 
homology to several Xanthomonas phages, including CP1 (NC_019933), Xop411 
(NC_009543), Xp10 (NC_004902), OP1 (NC_007709), phiL7 (NC_012742) and CP2 
(NC_020205). These phages are non-phiKMV-like, yet have homology and preserved 
gene order characteristic of phiKMV-like DNA metabolism regions, including a 
ssRNAP located at the end of the region. 
Structural and lysis genes  
The Xfas303 structural region is in the canonical phiKMV-like gene order. It 
begins immediately downstream of the ssRNAP, with three small genes for conserved 
proteins of hypothetical function (gp29-31) that are homologs to Cd1 gp27-29. Next in 
sequence are genes encoding a head-tail connector (gp32), scaffold protein (gp33), major 
capsid protein (gp34), tail tube A (gp36), tail tube B (gp37), and three internal virion 
proteins (gp38-gp40). Xfas303 gp40 possesses a C-terminal lysozyme-like domain 
(IPR023346), identical to that found in Cd1 gp38. However, Xfas303 gp40 is ~300aa 
larger than any previously reported homolog in phiKMV-like phages. As observed in 
other phages, there is diversity within the tail fiber proteins of the phiKMV-like phages, 
both in terms of sequence homology and components (149). In phiKMV-like phages, tail 
structural proteins are found immediately after the internal virion proteins. Similarly, the 
Xfas303 tail fiber proteins (gp41-44) are encoded in the same location. Xfas303 gp41 
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 contains a T7 tail fiber protein domain (IPR005604) and Xfas303 gp43 and gp44 have 
homologs to tail fiber proteins found in phiKMV-like phages. It appears, however that 
Xfas303 gp41-44 may have been acquired through horizontal gene transfer with a non-
phiKMV like phage. The four genes are found as a cluster and are homologs to genes 
gp26-29 in Xanthomonas phage CP2, with 30.6-41.1% identity.  
Xfas303 gp47 was assigned the function of TerL based on homology to other 
phiKMV-like phage TerL homologs in the database, and gp46 was designated as TerS 
based on its size and proximity to gp47. The lysis cassette of phage phiKMV has been 
studied in detail (150). The canonical phiKMV-like lysis cassette is organized with 
genes encoding for holin, endolysin, Rz and Rz1 found immediately downstream of 
TerS and TerL (150). The lysis cassette of Xfas303 is very similar to that of phiKMV. 
However, the predicted holin and endolysin are not found adjacent to each other. Instead 
they are separated by genes encoding for TerS (gp46), TerL (gp47) and a novel protein 
(gp48) (FIG 4).  
Xfas303 gp45 encodes a putative type II holin based on the presence of two 
TMDs (N-in, C-in). TMD2 (residues 31 to 48) is the most hydrophobic of the two. 
TMD1 (residues 13 to 29) is not predicted by TMHMM and has characteristics of a SAR 
domain, with a high percentage of weakly hydrophobic or polar residues. The class II 
topology and presence of a SAR domain followed by a typical TMD suggests that gp45 
is a pinholin, similar to phiKMV gp45 (150). Xfas303 gp49 encodes an endolysin, based 
on homology to other phiKMV-like phage endolysins in the database. Xfas303 
endolysin gp49 exhibits an N-terminal hydrophobic domain rich in weakly hydrophobic 
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 residues that is characteristics of a SAR endolysin (151). A glycoside hydrolase domain 
(IPR002196) is predicted by InterProScan and contains an E-8aa-D-8aa-T catalytic triad, 
similar to the E-8aa-D-5aa-T and E-9aa-D-6aa-T catalytic triads found in T4 protein E 
and phiKMV gp45, respectively (150, 152). However Xfas45 gp49 (173aa) is much 
smaller than the endolysin of phiKMV (898aa), and is more similar to the endolysin of 
Cd1 (185aa). SAR endolysins are embedded in the inner membrane where the enzyme is 
inactive. This prevents premature lysis and results in holin control of lysis timing (153).  
Xfas303 spanins were identified by characteristic gene orientation and proximity to the 
endolysin. Xfas303 Rz (gp50) and Rz1 (gp51) are subunits of a typical P2-like 
overlapped two component spanin complex, similar to that in phiKMV (150). Xfas303 
gp52 is homologous with HslV family proteins of Xanthomonas phages OP1 (gp51), 
Xp10 (gp51) and Xop411 (gp51), with 38.4-42.1% identity, but does not contain the N-
terminal hydrolase domain present in the other proteins.  
Phage lifestyle  
Based on genomic analysis, we can confidently predict that phages Xfas303 and 
Xfas304 are virulent, because they are phiKMV-like.  The same confidence cannot be 
assigned to Xfas103 and Xfas106. Phages BcepNazgul, Xfas103 and Xfas106 all encode 
a small protein with a helix-turn-helix DNA-binding domain (gp73, gp75, and gp70, 
respectively). Similar proteins have been annotated as cro-like proteins in phages AH2, 
Enc34, Chi and Redjac (139-142). This would suggest that the BcepNazgul-like phages 
may have a temperate lifestyle. However, other than AH2, key genes required for 
lysogeny were not found in these phages. AH2 is predicted to encode three excisionase 
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proteins (gp30, gp31 and gp33) and an integrase (gp37). Homologs to these genes are 
not present in the other BcepNazgul-like phages. Furthermore, the AH2 excisionase and 
integrase genes are encoded in two adjacent transcriptional unites (based on coding 
strand position) not present in other BcepNazgul-like phages (FIG 2). This suggests that 
the BcepNazgul-like phages, excepting AH2, have diverged to become virulent, due to a 
possible ancient deletion of lysogeny-related genes. Phage AH2 is BcepNazgul-like, 
which brings into question whether phages with different lifestyles can truly be the same 
phage type.  
To further examine the potential for lysogeny, 40 phage-insensitive isolates of 
strain Temecula and EC-12 each were recovered following a challenge by phage 
Xfas103, Xfas106, Xfas303, or Xfas304. PCR using phage specific primers did not 
detect the presence of phage lysogens in resistant isolates, indicating resistance was not 
due to lysogeny. However, the absence of stable lysogen formation is not a definitive 
indication for virulence (134). Additionally, we examined the effect of phage infection at 
a high MOI on cell survival, as previously described by Gill et al (134). As shown in 
TABLE 8, following phage exposure to Xfas103 or Xfas303, there was an observed 3.9-
fold and 3.46-fold excess of survivors than would be predicted, respectively. The 
observed higher percent survival may be due to the high degree of reversible binding of 
Xfas103 and Xfas303 to strain EC-12 (55 and 46%, respectively). The observed excess 
percent survival of strain EC-12 following exposure to Xfas103 and Xfas303 (predicted 
virulent phage) was similar, and does not support the notion that Xfas103 is temperate. 
  
 
TABLE 8 Actual MOI and predicted and actual bacterial survivors of Xanthomonas strain EC-12 following 
exposure to phage Xfas103 or Xfas303a 
 Replicate No. MOIactual Predicted % surviving 
cells 
Measured % surviving 
cells 
Fold excess of survivors vs. 
prediction 
Xfas103 1  2.64  7.14 26.1  3.65 
 2  2.78  6.20 22.1  3.56 
 3  2.88  5.61 25.7  4.58 
Xfas303 1  2.81  6.02 13.9  2.30 
 2  3.31  3.65 12.7  3.47 
 3  3.67  2.55 11.8  4.62 
a Predicted survivors were calculated from the Poisson distribution for the measured actual MOIs. Data shown 
are from three independent replicate experiments. 
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 CHAPTER IV 
RECEPTOR SITE IDENTIFICATION 
 
Introduction 
The susceptibility of a bacterium to phage infection is primarily dependent on 
whether or not the phage can adsorb to a specific attachment site(s) or receptor(s) on the 
cell surface (59). Since phages, like any other viruses, are obligate intracellular parasites, 
successful penetration into bacterial cell is an essential condition for continuation of 
their life cycle. A successful irreversible attachment may then be followed by the 
penetration of the phage nucleic acid into the cell, followed by intracellular replication 
of phage nucleic acid, ultimately leading in the release of new phage progeny (59).  
The recognition of the receptor is a highly specific process and is part of the 
natural mechanism of host recognition (154). The cell surfaces of both Gram-negative 
and Gram-positive bacteria have been studied intensively from structural, biosynthetic, 
genetic, and functional viewpoints. As a result of these studies information of 
considerable value for investigations of phage receptor sites has emerged (59).  Phages 
can use bacterial capsules, different components of lipopolysaccharide (LPS), flagella, 
fimbriae, outer membrane proteins or pili as receptors. Type IV pili (T4P) have been 
previously identified as phage receptors for several P. aeruginosa phages, including 
PO4, PP7, Pf, F116, D3112, DMS3, and B3 (60-66). Phages may also use enzymes to 
break down capsule-like materials on the bacterial surface to reach the cell wall of the 
bacterium (155). By mutating or losing a phage receptor, bacteria become resistant to 
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 phages. Resistance may reduce the fitness of the bacteria or, if the receptor is a virulence 
determinant, the pathogen may have reduced virulence (106, 156). In bacterial 
populations of 106–108 bacteria, there is a high possibility of spontaneous phage-
resistant mutants deficient in the receptor or with an altered receptor. It is therefore 
imperative the phage cocktails be composed of phages that recognize a diversity of 
receptors to avoid the development of phage resistance populations.  
It has been reported that T4P are an essential virulence factor in X. fastidiosa and 
that insertion mutations in genes involved in T4P biogenesis such as pilB and pilQ result 
in loss of twitching motility, inhibition of basipetal movement in planta, and the ability 
to cause disease (10). It was on interest to determine if T4P acted as a receptor site for 
the Xfas phages.  Here it is described the experimental determination of the primary 
receptor site for Xfas103, Xfas106, Xfas303 and Xfas304. 
Materials and methods 
Bacterial strains and culture conditions  
Bacterial strains and plasmids used in this study are listed in TABLE 9. X. 
fastidiosa strains were cultured at 28°C in PW-M broth (PW-MB) (25) or PW-M agar 
plates [PW-MA; PW-MB amended with 20 g/liter plant cell culture tested agar (Sigma)] 
(115). PW-M soft agar (PW-MSA, PW-MB amended with 7.5 g/liter plant cell culture 
tested agar) was used for overlays. PD3 amended agar (20 g/liter) (157) was used for 
preparation of electrocompetent cells and transformations. For X. fastidiosa cultures 
carrying antibiotic resistance cassettes or plasmids, the medium was supplemented with 
chloramphenicol (Cm) (5 µg/ml) or kanamycin (Km) (5 µg/ml). Xanthomonas strains 
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were cultured at 28°C in tryptone nutrient broth (TNB) (116) or tryptone nutrient agar 
(TNA; TNB lacking KNO3 and amended with 20 g/liter agar). TNA soft agar (TNSA, 
TNB lacking KNO3 and amended with 7.5 g/liter agar) was used for overlays. For 
Xanthomonas cultures harboring plasmids, the medium was supplemented with Km (50 
µg/ml). Yeast tryptone broth (YTB: 10 g/liter tryptone, 10 g/liter yeast extract) and 
yeast-tryptone agar amended with sucrose [YTSA; YTB amended with 20 g/liter, 
sucrose final concentration 15% (wt/vol)] were used for resolution of mutants.  
Escherichia coli strains were cultured at 37°C in LB broth or LB agar (158). For E. coli 
harboring plasmids, medium was supplemented with Cm (50 µg/ml), Km (50 µg /ml) or 
ampicillin (Amp) (100 µg /ml), as appropriate. 
Construction of strain Temecula pilA deletion mutant and in trans complementation  
Deletion of pilA in strain Temecula was performed as described by Feil (163) and 
modified by Matsumoto (161), with additional modifications. The pilA (NP_780105.1) 
open reading frame (ORF) from 2,256,755 to 2,257,201 (X. fastidiosa Temecula1, 
NC_004556.1) was removed and replaced with a Km resistance cassette by site-directed 
gene replacement. All plasmid constructs were generated using E. coli DH5α MCR as 
 
  
  
 
TABLE 9 Bacterial strains and plasmids used in this study 
Strain or 
plasmid 
Genotype and relevant features a Reference or 
source 
X. fastidiosa   
    Temecula1 PD strain (subsp. fastidiosa) (ATCC 700964) (12) 
    XF15-1-1 XF15-1, NS1::Cmr pilA This study 
    TM1 Temecula1; PD1693::Tn5 (4) 
    tonB1 Temecula;  PD0843::Tn5 (159) 
Xanthomonas   
    EC-12 Xanthomonas sp., rice isolate This study 
    EC-12-1 EC-12, unmarked deletion of pilA This study 
    EC-12-1-1 EC-121, pMo168::pilA This study 
E.  coli   
    DH5αMCR F— Ф80lacZΔM15 Δ(lacZYA-argF) recA1 endA1gyrA96 thi-1hsdR17supE44 relAl deoR  
U169 
Life Tech., 
Inc. 
(Gaithersburg, 
Md.) 
Plasmids   
    pUC19 pMB1 replicon, cloning vector, Apr (160) 
    pSJA101 Isogenic to pUC19; Temecula pilA-downstream flanking region cloned into XmaI and XbaI 
site 
This study 
    pSJA102 Isogenic to pSJA101; Kmr cassette cloned into KpnI and XmaI site This study 
    pSJA103 Isogenic to pSJA102; Temecula pilA-upstream flanking region cloned into SacI and KpnI site This study 
    pAX1Cm Cmr cassette and multiple-cloning site on pAX1 backbone (161) 
    pSJA104 Isogenic to pAX1Cm; Temecula pilA cloned into XbaI and XhoI site This study 
    pMo130 Suicide vector for allelic exchange; ColE1 ori, RK2 oriT, xylE, sacB, Kmr (162) 
    pSJA105 Isogenic to pMo130; EC-12 pilA-upstream flanking region cloned into NheI and BglII site This study 
    pSJA106 pSJA105 with EC-12 pilA-downstream flanking region cloned into BglII and HindIII site This study 
    pMo168 Replicative vector; ori pBBR1, mob+, xylE, Kmr (162) 
    pSJA107  pMo168::EC-12 pilA This study 
a Ap, ampicillin; Cm, chloramphenicol; Km, kanamyacin. 
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 host. Two 1-kb fragments flanking upstream and downstream of pilA were amplified 
from strain Temecula genomic DNA, using primers with added restriction sites. The 1-
kb fragment downstream of pilA was amplified using 
5’ATAACACCCGGGTGAATACACACAGCAACAC G-3’ (the XmaI site is 
underlined) and 5’-GTAATATCTAGAGCGCAGGGAAACGATGGAAGGT-3’(the 
XbaI site is underlined). The 1-kb PCR product was digested with XmaI and XbaI, and 
cloned into pUC19, resulting in pSJA101. The Km resistance gene cassette from 
pXF004 was amplified using 5’- 
GCGGCGGGTACCTCGATGAATTGTGTCTCAAAA-3’ (the KpnI site is underlined) 
and 5’-AGCAGCCCCGGGTTAGAAAAACTCATCGAGCAT-3’ (the XmaI site is 
underlined). The PCR product was digested with KpnI and XmaI and cloned into 
pSJA101, resulting in pSJA102. The 1-kb fragment upstream of pilA was amplified 
using 5’-ATAATAGAGCTCGAGAGCAACCGCGACAATAGCA-3’ (the SacI site is 
underlined) and 5’- GCGGCGGGTACCGTGTATACCTTCAATAAAAAG-3’ (the 
Kpn1 site is underlined). The 1-kb PCR product was digested with SacI and KpnI, and 
cloned into pSJA102, resulting in pSJA103. pSJA103  was introduced into strain 
Temecula by electroporation  as described (161) and transformants were selected on 
PW-MA containing Km.  The deletion of pilA and Km replacement was confirmed by 
sequencing from upstream and downstream of pilA. 
Complementation of the strain Temecula pilA deletion mutant, XF15-1, was 
accomplished by introducing a wild-type copy of pilA using a chromosome-based 
complementation system as described by Matsumoto (161). Briefly, pilA with its 
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 regulatory region was amplified from genomic DNA using 5’- 
GCGGCGTCTAGATTCTGGAAGAATGGATCG-3’ (the XbaI site is underlined) and 
5’- AGGTGTCTCGAGTTATTTAGCGGCAGTGCA-3’ (the XhoI site is underlined). 
The 0.66 kb PCR product was digested with XbaI and XhoI, and cloned into pAX1Cm, 
resulting in pSJA104, and transformed into strain XF15-1 by electroporation. 
Transformants were selected on PW-MA-Cm (5 µg/ml), and individual colonies were 
streak purified three times on selective medium. Insertion of pilA and Cmr cassette into 
the neutral site (NS1) of putative complements was confirmed by PCR amplification 
using primers pair NS1-f and NS1-r (161), and sequenced for confirmation (Eton 
Bioscience). 
Construction of strain EC-12 pilA deletion mutant and in trans complementation  
Deletion and complementation of pilA in strain EC-12 was performed as 
described by Hamad et al. (162) with modifications. PCR primers were designed based 
on the annotated pilA sequence of strain EC-12 draft genome (Das et al., unpublished). 
All plasmid constructs were generated using E. coli DH5α MCR as host. A 1.0 kb 
fragment upstream of pilA was amplified using 5’- 
GCGGCGGCTAGCTTTGAAGACATCTTCGAATTG-3’ (the NheI site is underlined) 
and 5’-ATGGCCAGATCTAATGTA CCCCTAGAGATGGTGT-3’ (the BglII site is 
underlined). The PCR product was digested with NheI and BglII, and cloned into 
multiple cloning site (MCS) 1 of plasmid pMo130, to obtain plasmid pSJA105. A 1.0 kb 
fragment downstream of pilA was amplified using 5’- 
GCGCGCAGATCTGATTCGGTTGGATGGTTTTGAT-3’ (the BglII site is underlined) 
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 and 5’-ATAAATAAGCTTTTGACCGGCGCCTTGGCCACGC-3’ (the HindIII site is 
underlined). The PCR product was digested with BglII and HindIII and cloned into 
pSJA105, to obtain pSJA106.  Plasmid pSJA106 was introduced into electrocompetent 
EC-12 cells by electroporation as previously described (163). Cells were allowed to 
recover in TNB for 3 h at 28oC before being dilution plated on TNA Km (50 µg/ml). 
After 72 h, resulting colonies were exposed to a mist of 0.45 M pyrocatechol to identify 
colonies in which single crossover events had occurred. Single yellow colonies were 
grown in YTB for 9 h and then plated to YTSA to select for resolved co-integrants. 
Colonies grown on YTSA were sprayed with pyrocatechol, and presumptive resolved 
co-integrants (exhibiting a white phenotype) were confirmed by sequencing across pilA 
upstream and downstream, to confirm pilA deletion. 
To complement EC-12 pilA deletion mutant EC-12-1, wild-type pilA was 
introduced using a derivative of the replicative plasmid pMo168. PilA, with its 
regulatory region, was amplified from EC-12 genomic DNA using 5’-
GCGGCGGCTAGCCTTATCCGTCAACACCAT-3’ (the NheI site is underlined) and 
5’- GTGAATAAGCTTTTACTGACAGGTCGCCGGGGC-3’ (the HindIII site is 
underlined). The 0.47 kb PCR product was digested with NheI and HindIII and cloned 
into pMo168 MCS-1, resulting in pSJA107. Recombinant plasmid pSJA107 was 
transformed into EC-12-1 as described above, and plated on TNA Km 50 µg/ml for 
selection at 28°C. Transformants were sprayed with 0.45 M pyrocatechol to identify 
colonies containing pSJA107, and the presence of the wild-type pilA was confirmed by 
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 PCR amplification using different combinations of primers. All PCR products were 
sequenced for confirmation. 
Twitching motility assay 
 To assay twitching motility, late log phase liquid cultures of strain Temecula (5 
day), EC-12 (18h) and their derivatives were centrifuged and resuspended to 200 μl in 
liquid medium as appropriate. Five microliter cell suspensions (1 ൈ 109 CFU/ml) were 
spotted to appropriate solid medium modified with 1.2% agar, and incubated at 28˚C 
[Temecula and derivatives (5 day) and strain EC-12 and derivatives (18h)]. 
Pseudomonas aeruginosa strain PAO1 grown in a similar manner at 37˚C for 24h, was 
used as positive control. Following incubation, colony edge morphology was visualized 
using an SZ-PT Olympus Microscope equipped with QImaging Go-21 CMOS camera 
system. 
Results and discussion  
Our preliminary results demonstrated that two transposon insertion mutants of 
strain Temecula, TM1 (unpiliated) (159)  and “tonB1 mutant” (hyperpiliated) (4), were 
resistant to phages Xfas103, Xfas106, Xfas303, and Xfas304, indicating the four phages 
may be T4P dependent. To confirm these observations, we generated T4P mutants (in-
frame deletions of pilA) in strains Temecula and EC-12, and tested for phage sensitivity 
with homologous propagated phage of each of the four phages, individually. PilA is the 
major subunit of T4P, and is required for T4P formation (164). Wild type Temecula and 
EC-12, both exhibited twitching motility (indicative of pilus retraction) (FIG 5 A,D 
respectively) and were sensitive to all four phages. ∆pilA derivatives, XF15-1 and EC-
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 12-1, were devoid in twitching motility (FIG 5B,E respectively) and were resistant to all 
four phages. Twitching motility and phage sensitivity were restored in XF15-1and EC-
12-1 by complementation of pilA in trans (FIG 5C,F respectively), providing evidence 
that the four phages utilize T4P as primary receptors to infect strains Temecula and EC-
12. However, it is not clear which component of the T4P is recognized by each phage. 
There is evidence that PilA is not the phage receptor in P. aeruginosa. Wild type P. 
aeruginosa strain PAK is sensitive to PO4 and resistant to phi6, whereas P. syringae 
strain DC3000 is sensitive to phi6 and resistant to PO4. The expression of P. syringae 
pilA in P. aeruginosa PAK has been shown to restore sensitivity to PO4 and confer 
sensitivity to phi6, indicating that a minor pilus-associated protein may indeed be the 
receptor site (165). 
It is not clear if the described phages replicate on Xanthomonas and/or X. 
fastidiosa in the environment. The genomes of Xfas103, Xfas106, Xfas303 and Xfas304 
have an average GC content of 63.5%, that is similar to that of sequenced Xanthomonas 
spp. (63.6-65.3%) and Xanthomonas phages (60%) (166); but higher than that of X. 
fastidiosa strains (49-55.6%) (167), suggesting the phages evolved in Xanthomonas. 
However, allopatric speciation would suggest if the phages had separated from one host 
for too long, they would lose the ability to adsorb and replicate in that host. Both genera 
are members of the Xanthomonadaceae and are associated with a broad range of plant 
hosts, where they do not necessarily cause disease (6, 168).  The Xanthomonas and X. 
fastidiosa genomes are diverged, yet both have retained T4P, a required virulence factor 
in both X. fastidiosa  (3) and Xanthomonas (169-172). Phylogenetic analysis suggests 
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FIG 5 Bacterial colony edge morphology and twitching motility. Colony edge 
morphology and twitching motility for (A) wild-type strain Temecula, (B) strain 
Temecula ΔpilA mutant, (C) strain Temecula ΔpilA complement, (D) wild-type 
Xanthomonas strain EC-12, (E) strain EC-12 ΔpilA mutant and (F) strain EC-12 ΔpilA 
complement. Cultures of X. fastidiosa or Xanthomonas were spotted to appropriate solid 
medium modified with 1.2% agar, and incubated at 28˚C [X. fastidiosa (5 day) and 
Xanthomonas (18h)]. Wild type isolates exhibit twitching motility, ΔpilA mutants do not 
exhibit twitching motility, and complements are restored. 
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 there is divergence in the T4P pilE-fimT cluster within the Xanthomonadaceae (6). X. 
fastidiosa contains two copies of the cluster, whereas X. axonopodis pv. citri has lost one 
copy and X. campestris pv. campestris has lost the other (6). We speculate that 
overlapping plant host ranges and shared environmental niches, along with the 
conservation of T4P in both Xanthomonas and X. fastidiosa, has led to the selection of 
phages able to adsorb and replicate in both genera. 
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 CHAPTER V 
CONCLUSIONS 
 
In medicine and agriculture, the search for innovative solutions to control disease 
is an ongoing process. Currently, there are no economic or environmentally sustainable 
solutions for control of disease caused by X. fastidiosa. The wide host range of this 
pathogen has implications for economically important crops such as grape, citrus and 
coffee.  Phage therapy offers a novel and environmentally acceptable treatment for the 
control of disease caused by X. fastidiosa.   
In this study, I have developed a surrogate system using Xanthomonas that 
allows for the efficient isolation and propagation of phages from the environment for X. 
fastidiosa. Prior to this study, the only propagated phage was temperate phage Xfas53 
isolated from supernatants of X. fastidiosa strain XF53. Phages Xfas53 which appears to 
have been formed by recombination between a widespread family of X. fastidiosa P2-
related prophage elements and a podophage distantly related to phage P22 (115). 
As noted in the prior text, temperate phage are not suitable for a phage based 
biocontrol system for control of disease caused by X. fastidiosa. During this study, I  
isolated  and characterized the first virulent phages for X. fastidiosa , Xfas103, Xas106, 
Xfas303 and Xfas304, with  a host range that extended to several species of  
Xanthomonas, including X. axonopodis pv. citri and X. euvesicatoria.  
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 Adsorption rate constants determined for the four phages strain showed that as 
with phage Xfas53, the four phages exhibited unusually slow adsorption kinetics, 
possibly an adaptation to the confined niche of their slow-growing host. 
I proposed that phage BcepNazgul is the founder of a novel phage type based on 
its unique genomic organization as compared to existing phage types, and that phages 
Xfas103 and Xfas106 belong to this new group. The genomes of this new group 
consisted of four divergent transcriptional units based on coding strand position, with 
genes found in transcriptional unit one and two primarily encoding proteins of unknown 
function, and genes found in transcriptional units three and four encoding the lysis 
cassette, structural module and DNA metabolism modules. I further proposed, based on 
genomic analysis that podophages Xfas303 and Xas304 are members of the virulent 
phiKMV-like group.  
I determined the shared receptor site of all four phages by constructing deletion 
mutants in the pilA of X. fastidiosa strain Temecula and Xanthomonas strain EC-12. 
Mutants were impaired in twitching motility and were resistant to all four phages, 
whereas the complements were restored to wild-type phenotype and were phage 
sensitive. This confirmed that the Type IV pili are receptor for all four phages in both 
hosts.  
The development of the surrogate system and the availability to isolate and 
propagate virulent phages for X. fastidiosa now provides the opportunity for the 
development of a phage based biocontrol system for disease caused by X. fastidiosa. 
Phage therapy offers compelling advantages for antibacterial therapy because of two 
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 properties: specificity and exponential propagation. Phages specifically target the 
pathogen, without posing any harmful effects to humans, animals, and plants or 
associated beneficial microflora.   
 Future studies will include the testing of the efficacy of a phage based biocontrol 
system for control of Pierce’s Disease in grape and determining the movement and 
persistence of phage in plants.  
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